Skip Navigation
Skip to contents

JMD : Journal of Movement Disorders

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
25 "Movement disorder"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Brief communication
Quantification of loudness instability in tone production in embouchure dystonia
André Lee, Tobias Mantel, Shinichi Furuya, Masanori Morise, Eckart Altenmüller, Bernhard Haslinger
Received September 3, 2025  Accepted December 22, 2025  Published online December 24, 2025  
DOI: https://doi.org/10.14802/jmd.25235    [Accepted]
  • 274 View
  • 17 Download
AbstractAbstract PDF
Embouchure dystonia (ED) is a task-specific disorder of voluntary fine motor control that has a severe impact on musicians’ ability to perform. One critical skill for professional musicians is the ability to produce sustained notes with an even loudness, however this ability in ED has not been well defined. The present study therefore examined the time-varying dynamics of loudness in ED compared to healthy musicians, as well as its relationship to F0 variability, applying sound analysis of sustained notes. The findings revealed a significantly greater varia-bility with respect to both loudness and F0 among ED patients. Furthermore, loudness and F0 variability were strongly correlated, suggesting a shared pathological basis. We conclude that F0 variability and loudness instability are reliable measures for objectively characterising ED and assisting accurate diagnosis. The incorporating of quantitative acoustic tools into future diagnostic and therapeutic frameworks has the potential to enhance the objectivity and repro-ducibility of ED assessment.
Review Article
Article image
Functional Movement Disorders: Updates and Clinical Overview
Jung E Park
J Mov Disord. 2024;17(3):251-261.   Published online July 1, 2024
DOI: https://doi.org/10.14802/jmd.24126
  • 25,390 View
  • 1,070 Download
  • 8 Web of Science
  • 12 Crossref
AbstractAbstract PDF
Functional movement disorder (FMD) is a type of functional neurological disorder that is common but often difficult to diagnose or manage. FMD can present as various phenotypes, including tremor, dystonia, myoclonus, gait disorders, and parkinsonism. Conducting a clinical examination appropriate for assessing a patient with suspected FMD is important, and various diagnostic testing maneuvers may also be helpful. Treatment involving a multidisciplinary team, either outpatient or inpatient, has been found to be most effective. Examples of such treatment protocols are also discussed in this review. While recognition and understanding of the disorder has improved over the past few decades, as well as the development of treatments, it is not uncommon for patients and physicians to continue to experience various difficulties when dealing with this disorder. In this review, I provide a practical overview of FMD and discuss how the clinical encounter itself can play a role in patients’ acceptance of the diagnosis. Recent neuroimaging studies that aid in understanding the pathophysiology are also discussed.

Citations

Citations to this article as recorded by  
  • A review of treatment methods for movement disorders
    Mahdi Khezri, Shakiba Afsar
    Behavioural Brain Research.2026; 500: 115979.     CrossRef
  • Practical assessment of motor preparation–execution coupling during active ankle dorsiflexion in post-stroke gait: A pilot study
    Hiroki Ito, Hideaki Yamaguchi, Kazumasa Ukai, Ryosuke Yamauchi, Ken Kitai, Takayuki Kodama
    Clinical Neurophysiology Practice.2026; 11: 54.     CrossRef
  • Reduced microstructural white matter integrity is associated with the severity of physical symptoms in functional neurological disorder
    Nicolas Gninenko, Eliane Müller, Selma Aybek
    NeuroImage: Clinical.2025; 46: 103791.     CrossRef
  • Functional Movement Disorder: Evolving Mechanisms, Diagnostic Precision, and Personalized Multidisciplinary Care
    Emmanuel Ortega‐Robles, Ali Shalash, Jesús Ramírez‐Bermúdez, Oscar Arias‐Carrión
    Movement Disorders Clinical Practice.2025; 12(9): 1244.     CrossRef
  • Clinical Profile of Functional Neurological Disorder
    Bruno Gabriel Dal Pasquale, Marcelo Daudt von der Heyde, Hélio Afonso Ghizoni Teive
    The Open Neurology Journal.2025;[Epub]     CrossRef
  • Bewegungsstörungen – Notfälle
    Christian J. Hartmann, Alfons Schnitzler
    Notaufnahme up2date.2025; 07(03): 261.     CrossRef
  • Emerging Trends in Functional Movement Disorders Consultations and the Impact of a Major Life Event
    Daniel S. Marín‐Medina, Gala Lopez, Malco Rossi, Marcelo Merello
    Movement Disorders Clinical Practice.2025;[Epub]     CrossRef
  • Trastornos de la marcha
    S. Aguilera Albesa, R. Bernadó Fonz, P. Arana Rivera
    Pediatría Integral.2025; : 442.     CrossRef
  • A Scoping Review of Measures Used to Assess Stress-Related Motor Dysfunction in Functional Movement Disorder
    Chelsea Kinney, Mary Shotwell
    Tremor and Other Hyperkinetic Movements.2025; 15: 49.     CrossRef
  • Epidemiology of Functional Neurological Disorder: The Clinical Spectrum
    Emma Woo, Gabriela S. Gilmour
    Seminars in Neurology.2025;[Epub]     CrossRef
  • Functional Tremor
    Kartika Gulati, Sanjay Pandey
    Seminars in Neurology.2025;[Epub]     CrossRef
  • Clinical insights into movement disorders in children: A review of etiology, diagnosis, and treatment options
    Aron Christy, Ramya A
    IP International Journal of Medical Paediatrics and Oncology.2024; 10(4): 103.     CrossRef
Brief communication
Article image
COVID-19 Vaccine-Related Movement Disorders: A Systematic Review
Grace Elysse D. Angeles, Lowrence Precious C. Dichoso, Roland Dominic G. Jamora
J Mov Disord. 2024;17(3):322-327.   Published online March 19, 2024
DOI: https://doi.org/10.14802/jmd.24001
  • 16,895 View
  • 220 Download
  • 2 Comments
AbstractAbstract PDFSupplementary Material
Objective
Since the release of vaccines against coronavirus disease 2019 (COVID-19), there have been reports of vaccine-related neurologic complications. This study aimed to perform a descriptive systematic review of movement disorders associated with COVID-19 vaccines.
Methods
We described the demographics, clinical presentation, management, outcomes, and proposed pathomechanism of the patients. A systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A standardized tool was used to assess the quality of the cases.
Results
We identified 8 articles that met our inclusion criteria; these articles included 10 patients who developed movement disorders after vaccination. The majority were males (n = 8), with a median age of 64.5 years. The most common movement disorder was hemichorea. The rest presented with generalized chorea with myoclonus, cervical dystonia, and akathisia. Most patients respond to immunotherapy. The standardized tool used showed that most studies had a low risk of bias.
Conclusion
The reported incidence of vaccine-related movement disorders was low based on available published cases.
Review Articles
Article image
Nine Hereditary Movement Disorders First Described in Asia: Their History and Evolution
Priya Jagota, Yoshikazu Ugawa, Zakiyah Aldaajani, Norlinah Mohamed Ibrahim, Hiroyuki Ishiura, Yoshiko Nomura, Shoji Tsuji, Cid Diesta, Nobutaka Hattori, Osamu Onodera, Saeed Bohlega, Amir Al-Din, Shen-Yang Lim, Jee-Young Lee, Beomseok Jeon, Pramod Kumar Pal, Huifang Shang, Shinsuke Fujioka, Prashanth Lingappa Kukkle, Onanong Phokaewvarangkul, Chin-Hsien Lin, Cholpon Shambetova, Roongroj Bhidayasiri
J Mov Disord. 2023;16(3):231-247.   Published online June 13, 2023
DOI: https://doi.org/10.14802/jmd.23065
  • 11,237 View
  • 331 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract PDFSupplementary Material
Clinical case studies and reporting are important to the discovery of new disorders and the advancement of medical sciences. Both clinicians and basic scientists play equally important roles leading to treatment discoveries for both cures and symptoms. In the field of movement disorders, exceptional observation of patients from clinicians is imperative, not just for phenomenology but also for the variable occurrences of these disorders, along with other signs and symptoms, throughout the day and the disease course. The Movement Disorders in Asia Task Force (TF) was formed to help enhance and promote collaboration and research on movement disorders within the region. As a start, the TF has reviewed the original studies of the movement disorders that were preliminarily described in the region. These include nine disorders that were first described in Asia: Segawa disease, PARK-Parkin, X-linked dystonia-parkinsonism, dentatorubral-pallidoluysian atrophy, Woodhouse-Sakati syndrome, benign adult familial myoclonic epilepsy, Kufor-Rakeb disease, tremulous dystonia associated with mutation of the calmodulin-binding transcription activator 2 gene, and paroxysmal kinesigenic dyskinesia. We hope that the information provided will honor the original researchers and help us learn and understand how earlier neurologists and basic scientists together discovered new disorders and made advances in the field, which impact us all to this day.

Citations

Citations to this article as recorded by  
  • Genetic heterogeneity of early onset Parkinson disease: The dilemma of clinico-genetic correlation
    Roopa Rajan, Vikram V. Holla, Nitish Kamble, Ravi Yadav, Pramod Kumar Pal
    Parkinsonism & Related Disorders.2024; 129: 107146.     CrossRef
Article image
Historical and More Common Nongenetic Movement Disorders From Asia
Norlinah Mohamed Ibrahim, Priya Jagota, Pramod Kumar Pal, Roongroj Bhidayasiri, Shen-Yang Lim, Yoshikazu Ugawa, Zakiyah Aldaajani, Beomseok Jeon, Shinsuke Fujioka, Jee-Young Lee, Prashanth Lingappa Kukkle, Huifang Shang, Onanong Phokaewvarangkul, Cid Diesta, Cholpon Shambetova, Chin-Hsien Lin
J Mov Disord. 2023;16(3):248-260.   Published online June 9, 2023
DOI: https://doi.org/10.14802/jmd.22224
  • 7,502 View
  • 184 Download
  • 2 Web of Science
  • 2 Crossref
AbstractAbstract PDFSupplementary Material
Nongenetic movement disorders are common throughout the world. The movement disorders encountered may vary depending on the prevalence of certain disorders across various geographical regions. In this paper, we review historical and more common nongenetic movement disorders in Asia. The underlying causes of these movement disorders are diverse and include, among others, nutritional deficiencies, toxic and metabolic causes, and cultural Latah syndrome, contributed by geographical, economic, and cultural differences across Asia. The industrial revolution in Japan and Korea has led to diseases related to environmental toxin poisoning, such as Minamata disease and β-fluoroethyl acetate-associated cerebellar degeneration, respectively, while religious dietary restriction in the Indian subcontinent has led to infantile tremor syndrome related to vitamin B12 deficiency. In this review, we identify the salient features and key contributing factors in the development of these disorders.

Citations

Citations to this article as recorded by  
  • Diabetic striatopathy and other acute onset de novo movement disorders in hyperglycemia
    Subhankar Chatterjee, Ritwik Ghosh, Payel Biswas, Shambaditya Das, Samya Sengupta, Souvik Dubey, Biman Kanti Ray, Alak Pandit, Julián Benito-León, Rana Bhattacharjee
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2024; 18(3): 102997.     CrossRef
  • Tremors in Infantile Tremor Syndrome Mimicking Epilepsia Partialis Continua
    Tonyot Gailson, Pradeep Kumar Gunasekaran, Arushi Gahlot Saini, Chaithanya Reddy
    Journal of Movement Disorders.2024; 17(3): 351.     CrossRef
Article image
Adult-Onset Genetic Leukoencephalopathies With Movement Disorders
Mu-Hui Fu, Yung-Yee Chang
J Mov Disord. 2023;16(2):115-132.   Published online March 7, 2023
DOI: https://doi.org/10.14802/jmd.22127
  • 20,018 View
  • 669 Download
  • 1 Web of Science
  • 1 Crossref
  • 1 Comments
AbstractAbstract PDF
Genetic leukoencephalopathies (GLEs) are a group of white matter abnormalities with heterogeneous radiological and phenotypic features. Although these conditions have mostly been described in children, adult-onset cases are increasingly recognized owing to the widespread use of neuroimaging and advances in molecular genetic testing. The disease course is often progressive with a varied spectrum of presentations, trapping neurologists in the dilemma of differential diagnosis. Movement disorders are among the most common symptoms, and their diversity makes diagnosis challenging. In this review, we focus on adult-onset GLEs with movement disorders and offer a step-by-step diagnostic approach by clarifying the phenomenology of movement, advising investigations for acquired causes, describing the clinical and radiological clues to each disease, emphasizing the limitations of advanced molecular testing, and discussing the future application of artificial intelligence. We provide a list summarizing the leukoencephalopathies associated with different categories of movement disorders. In addition to guiding clinicians on how to narrow the list of differential diagnoses with the tools currently available, another aim of this review is to emphasize the inevitable trend toward applying advanced technology in diagnosing these difficult diseases.

Citations

Citations to this article as recorded by  
  • A rare case of adult-onset vanishing white matter leukoencephalopathy with movement disorder, expressing homozygous EIF2B3 and PRKN pathogenic variants
    Bashar Kamal Ali Douden, Yazan Mohammad Abdullah Abufara, Mahmood Fayez Ali Aldrabeeh, Naela Ramadan Mohammad Tell, Ismail Abudaya
    BMC Neurology.2025;[Epub]     CrossRef
Article image
Treatable Ataxias: How to Find the Needle in the Haystack?
Albert Stezin, Pramod Kumar Pal
J Mov Disord. 2022;15(3):206-226.   Published online September 7, 2022
DOI: https://doi.org/10.14802/jmd.22069
  • 16,001 View
  • 802 Download
  • 6 Web of Science
  • 7 Crossref
AbstractAbstract PDF
Treatable ataxias are a group of ataxic disorders with specific treatments. These disorders include genetic and metabolic disorders, immune-mediated ataxic disorders, and ataxic disorders associated with infectious and parainfectious etiology, vascular causes, toxins and chemicals, and endocrinopathies. This review provides a comprehensive overview of different treatable ataxias. The major metabolic and genetic treatable ataxic disorders include ataxia with vitamin E deficiency, abetalipoproteinemia, cerebrotendinous xanthomatosis, Niemann-Pick disease type C, autosomal recessive cerebellar ataxia due to coenzyme Q10 deficiency, glucose transporter type 1 deficiency, and episodic ataxia type 2. The treatment of these disorders includes the replacement of deficient cofactors and vitamins, dietary modifications, and other specific treatments. Treatable ataxias with immune-mediated etiologies include gluten ataxia, anti-glutamic acid decarboxylase antibody-associated ataxia, steroid-responsive encephalopathy associated with autoimmune thyroiditis, Miller-Fisher syndrome, multiple sclerosis, and paraneoplastic cerebellar degeneration. Although dietary modification with a gluten-free diet is adequate in gluten ataxia, other autoimmune ataxias are managed by short-course steroids, plasma exchange, or immunomodulation. For autoimmune ataxias secondary to malignancy, treatment of tumor can reduce ataxic symptoms. Chronic alcohol consumption, antiepileptics, anticancer drugs, exposure to insecticides, heavy metals, and recreational drugs are potentially avoidable and treatable causes of ataxia. Infective and parainfectious causes of cerebellar ataxias include acute cerebellitis, postinfectious ataxia, Whipple’s disease, meningoencephalitis, and progressive multifocal leukoencephalopathy. These disorders are treated with steroids and antibiotics. Recognizing treatable disorders is of paramount importance when dealing with ataxias given that early treatment can prevent permanent neurological sequelae.

Citations

Citations to this article as recorded by  
  • Glycogénoses, hyperoxaluries, aminoacidopathies et hyperlipidémies : manifestations ostéoarticulaires
    G. Chalès, F. Robin, P. Guggenbuhl
    EMC - Appareil locomoteur.2026; 40(1): 1.     CrossRef
  • The role of α-tocopherol in the prevention and treatment of Alzheimer's disease
    Michał Pelczarski, Szymon Wolaniuk, Monika Zaborska, Jakub Sadowski, Anna Sztangreciak-Lehun, Rafał Jakub Bułdak
    Molecular and Cellular Biochemistry.2025; 480(6): 3385.     CrossRef
  • Hereditary Ataxias in Argentina
    Malco Rossi, Marcelo Merello
    The Cerebellum.2025;[Epub]     CrossRef
  • Unravelling the Global Tapestry of Genetic Ataxias: Epidemiology and Genetic Testing Approaches
    Malco Rossi, Christopher D. Stephen, Joana Damásio, José Luiz Pedroso, Sheng‐Han Kuo, Chi‐Ying R. Lin, Oluwadamilola Ojo, Shaimaa El‐Jaafary, Woong‐Woo Lee, Harutyun Madoev, Orlando G.P. Barsottini, Achal Kumar Srivastava, Christine Klein, Bart P. van de
    Movement Disorders.2025; 40(9): 1805.     CrossRef
  • Genetic Testing of Movements Disorders: A Review of Clinical Utility
    Dennis Yeow, Laura I. Rudaks, Sue-Faye Siow, Ryan L. Davis, Kishore R. Kumar
    Tremor and Other Hyperkinetic Movements.2024;[Epub]     CrossRef
  • Genetically Proven Ataxia With Vitamin E Deficiency With Predominant Cervicobrachial Dystonic Presentation: A Case Report From India
    Vikram V. Holla, Sandeep Gurram, Sneha D. Kamath, Gautham Arunachal, Nitish Kamble, Ravi Yadav, Pramod Kumar Pal
    Journal of Movement Disorders.2024; 17(2): 220.     CrossRef
  • Rehabilitation in Ataxia
    Anupam Gupta, Navin B. Prakash, Hafis Rahman
    Indian Journal of Physical Medicine and Rehabilitation.2023; 33(1): 21.     CrossRef
Article image
Diagnosis and Clinical Features in Autoimmune-Mediated Movement Disorders
Pei-Chen Hsieh, Yih-Ru Wu
J Mov Disord. 2022;15(2):95-105.   Published online May 26, 2022
DOI: https://doi.org/10.14802/jmd.21077
  • 11,590 View
  • 1,035 Download
  • 7 Web of Science
  • 8 Crossref
AbstractAbstract PDFSupplementary Material
Movement disorders are common manifestations in autoimmune-mediated encephalitis. This group of diseases is suspected to be triggered by infection or neoplasm. Certain phenotypes correlate with specific autoantibody-related neurological disorders, such as orofacial-lingual dyskinesia with N-methyl-D-aspartate receptor encephalitis and faciobrachial dystonic seizures with leucine-rich glioma-inactivated protein 1 encephalitis. Early diagnosis and treatment, especially for autoantibodies targeting neuronal surface antigens, can improve prognosis. In contrast, the presence of autoantibodies against intracellular neuronal agents warrants screening for underlying malignancy. However, early clinical diagnosis is challenging because these diseases can be misdiagnosed. In this article, we review the distinctive clinical phenotypes, magnetic resonance imaging findings, and current treatment options for autoimmune-mediated encephalitis.

Citations

Citations to this article as recorded by  
  • Neuropsychiatric Presentation of Non-paraneoplastic Voltage-Gated Calcium Channel Autoimmune Encephalitis: A Case Report
    Shreya Philip, Sandeep Kaur, Rajeshwar Sahonta, Jeyaraj D Pandian
    Cureus.2026;[Epub]     CrossRef
  • Encefalitis autoinmune asociada a anticuerpos anti-LGI1: revisión de sus aspectos clínicos, diagnósticos y terapéuticos
    Dianelys Herrada-de la Cruz, Luis Alberto A. Bustamante-Canales, Catalina Paz Silva-Carrasco, Rocío A. Faúndez-Silva
    Revista Médica Clínica Las Condes.2025; 36(3): 192.     CrossRef
  • Utility and Value of Movement Recording with Combined EEG-EMG Monitoring in the Intensive Care Unit
    Julie Lévi-Strauss, Clémence Marois, Yulia Worbe, Laurine Bedoucha, Raouf Benchikh Lehocine, Benjamin Rohaut, Nicolas Weiss, Sophie Demeret, Emmanuelle Apartis, Virginie Lambrecq
    Neurocritical Care.2025; 43(1): 333.     CrossRef
  • Decoding Autoimmunity: Insights Into Neuromyelitis Optica and Its Relationship With Other Autoimmune Neurological Disorders
    Tabish W Siddiqui, Raqshan W Siddiqui, Shiza W Siddiqui, Sohaila Fatima, Hiba R Babu, Uvashree Shrinivas, Leah L Dias, Jefina Olive
    Cureus.2025;[Epub]     CrossRef
  • The tongue muscles: Clinical applications in lingual dystonia
    Raymond L. Rosales, Nadine J. Endaya
    Toxicon.2025; 262: 108382.     CrossRef
  • The Spectrum of Abnormal Tongue Movements: Review of Phenomenology, Etiology, and Differential Diagnosis
    Nathaniel Bendahan, Seyed‐Mohammad Fereshtehnejad, Christos Ganos, Emily Swinkin, Anthony E. Lang
    Movement Disorders Clinical Practice.2025;[Epub]     CrossRef
  • A case of corticobasal syndrome possibly associated with anti-Yo antibodies
    Efthalia Angelopoulou, Vasilios C. Constantinides, Evangelos Koumasopoulos, Evangelia Stanitsa, Efstratios-Stylianos Pyrgelis, Andreas Kyrozis, Elisabeth Kapaki, Leonidas Stefanis, Sokratis G. Papageorgiou
    Current Medical Research and Opinion.2024; 40(10): 1737.     CrossRef
  • Movement disorders in autoimmune encephalitis: Clinical spectrum, prognosis, and outcomes from an Indian cohort
    Shreyashi Jha, Netravathi M, Vikram Venkappayya Holla, Nitish Kamble, Anita Mahadevan, Pramod Kumar Pal
    Annals of Movement Disorders.2024; 7(3): 189.     CrossRef
Article image
Gene Therapy for Huntington’s Disease: The Final Strategy for a Cure?
Seulgi Byun, Mijung Lee, Manho Kim
J Mov Disord. 2022;15(1):15-20.   Published online November 17, 2021
DOI: https://doi.org/10.14802/jmd.21006
  • 14,303 View
  • 548 Download
  • 29 Web of Science
  • 31 Crossref
AbstractAbstract PDF
Huntington’s disease (HD) has become a target of the first clinical trials for gene therapy among movement disorders with a genetic origin. More than 100 clinical trials regarding HD have been tried, but all failed, although there were some improvements limited to symptomatic support. Compared to other neurogenetic disorders, HD is known to have a single genetic target. Thus, this is an advantage and its cure is more feasible than any other movement disorder with heterogeneous genetic causes. In this review paper, the authors attempt to cover the characteristics of HD itself while providing an overview of the gene transfer methods currently being researched, and will introduce an experimental trial with a preclinical model of HD followed by an update on the ongoing clinical trials for patients with HD.

Citations

Citations to this article as recorded by  
  • A review of treatment methods for movement disorders
    Mahdi Khezri, Shakiba Afsar
    Behavioural Brain Research.2026; 500: 115979.     CrossRef
  • The Expanding Role of Non-Coding RNAs in Neurodegenerative Diseases: From Biomarkers to Therapeutic Targets
    Xuezhi Zhao, Yongquan Zheng, Xiaoyu Cai, Yao Yao, Dongxu Qin
    Pharmaceuticals.2026; 19(1): 92.     CrossRef
  • Translational Approach using Advanced Therapy Medicinal Products for Huntington's Disease
    Maryam Alsadat Mousavi, Maliheh Rezaei, Mahsa Pourhamzeh, Mehri Salari, Nikoo Hossein-Khannazer, Anastasia Shpichka, Seyed Massood Nabavi, Peter Timashev, Massoud Vosough
    Current Reviews in Clinical and Experimental Pharmacology.2025; 20(1): 14.     CrossRef
  • Exploring the role of ferroptosis pathways in Huntington's disease: Insight of pathophysiology to emerging treatment
    Mohd Haris Jamal, Meghna Dhupar, Khadga Raj Aran
    Brain Disorders.2025; 18: 100207.     CrossRef
  • Oligonucleotide-based therapeutics for neurodegenerative disorders: Focus on antisense oligonucleotides
    Heba M. Mansour, Aiman S. El-Khatib
    European Journal of Pharmacology.2025; 998: 177529.     CrossRef
  • Oxidative Stress: Pathological Driver in Chronic Neurodegenerative Diseases
    Zhao Zhong Chong, Nizar Souayah
    Antioxidants.2025; 14(6): 696.     CrossRef
  • Single pass tangential flow filtration (SPTFF) for concentration and purification of AAV clarified cell lysate
    Akshay S. Chaubal, Christopher J. Yehl, Mohammad A. Afzal, Lu Wang, Andrew L. Zydney
    Journal of Membrane Science.2025; 733: 124362.     CrossRef
  • Start the engine of neuroregeneration: A mechanistic and strategic overview of direct astrocyte-to-neuron reprogramming
    Hangyuan Jiang, Hengxing Qi, Anying Tang, Shaohua Hu, Jianbo Lai
    Ageing Research Reviews.2025; 110: 102808.     CrossRef
  • Cortical and Striatal Functional Connectivity in Juvenile-Onset Huntington’s Disease
    Amy Barry, Peg C. Nopoulos
    Brain Sciences.2025; 15(6): 663.     CrossRef
  • Intrathecal Therapies for Neurodegenerative Diseases: A Review of Current Approaches and the Urgent Need for Advanced Delivery Systems
    Thomas Gabriel Schreiner, Manuel Menéndez-González, Oliver Daniel Schreiner, Romeo Cristian Ciobanu
    Biomedicines.2025; 13(9): 2167.     CrossRef
  • Exosome‐Based Therapeutics: A Natural Solution to Overcoming the Blood–Brain Barrier in Neurodegenerative Diseases
    Min Sun, Feng Qin, Qian Bu, Yue Zhao, Xiaofeng Yang, Dingwen Zhang, Xiaobo Cen
    MedComm.2025;[Epub]     CrossRef
  • Novel therapies for lowering low-density lipoprotein levels for atherosclerotic cardiovascular disease prevention: reaching the target where others have failed
    Artur Dziewierz, Beata Bobrowska, Witold Streb, Francesco Pelliccia, Stanisław Bartuś, Renata Rajtar-Salwa
    Expert Review of Cardiovascular Therapy.2025; 23(11): 655.     CrossRef
  • CRISPR-Cas9: bridging the gap between aging mechanisms and therapeutic advances in neurodegenerative disorders
    Anas Shamsi, Mohammed Alrouji, Othman AlOmeir, Syed Tasqeruddin, Khuzin Dinislam, Azna Zuberi
    Frontiers in Cellular Neuroscience.2025;[Epub]     CrossRef
  • Upregulation of CCK3R leading to the suppression of chronic seizures
    Ling He, Liyang Zhang, Yujie Yang, Junming Ren, Zhoujian Xiao, Yihao Li, Yuandi Zhao, Feixu Jiang, Dingxuan Zeng, Xin Yan, Yanyan Sun, Jufang He
    Translational Psychiatry.2025;[Epub]     CrossRef
  • Overview of Huntington’s Disease and Emerging Treatment Strategies: A Narrative Review
    Alexis J Vega, Gabriel V Hernandez, Pearse A O'Malley, Connor J Robin, Amanda N Parra, Giustino Varrassi, Sahar Shekoohi, Alan D Kaye
    Cureus.2025;[Epub]     CrossRef
  • Epidemiology and economic burden of selected rare genetic diseases in Germany – a claims database study
    Marion Ludwig, Marco Alibone, Raeleesha Norris, Josephine Jacob, Vukasin Viskovic, Anja Cengia, Dominik Obermüller
    Orphanet Journal of Rare Diseases.2025;[Epub]     CrossRef
  • Bioinspired Approaches for Central Nervous System Targeted Gene Delivery
    Jyotish Kumar, Afroz Karim, Ummy Habiba Sweety, Hemen Sarma, Md Nurunnabi, Mahesh Narayan
    ACS Applied Bio Materials.2024; 7(8): 4975.     CrossRef
  • The Huntington's Disease Gene Discovery
    Gustavo L. Franklin, Hélio A.G. Teive, Fernando Spina Tensini, Carlos Henrique Ferreira Camargo, Nayra de Souza Carvalho de Lima, Diego de Castro de dos Santos, Alex T. Meira, Sarah J. Tabrizi
    Movement Disorders.2024; 39(2): 227.     CrossRef
  • Optimizing Screening for Intrastriatal Interventions in Huntington's Disease Using Predictive Models
    Matthew J. Barrett, Ahmed Negida, Nitai Mukhopadhyay, Jin K. Kim, Huma Nawaz, Jefin Jose, Claudia Testa
    Movement Disorders.2024; 39(5): 855.     CrossRef
  • Exosomes for neurodegenerative diseases: diagnosis and targeted therapy
    Hui Tao, Bo Gao
    Journal of Neurology.2024; 271(6): 3050.     CrossRef
  • Emerging Perspectives on Prime Editor Delivery to the Brain
    Eli BenDavid, Sina Ramezanian, Yaoyao Lu, Joël Rousseau, Avi Schroeder, Marc Lavertu, Jacques P. Tremblay
    Pharmaceuticals.2024; 17(6): 763.     CrossRef
  • Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington’s disease
    Alaa Shafie, Amal Adnan Ashour, Saleha Anwar, Farah Anjum, Md. Imtaiyaz Hassan
    Archives of Pharmacal Research.2024; 47(6): 571.     CrossRef
  • A comprehensive review of AAV-mediated strategies targeting microglia for therapeutic intervention of neurodegenerative diseases
    Livia Zhou, Yafeng Wang, Yiran Xu, Yaodong Zhang, Changlian Zhu
    Journal of Neuroinflammation.2024;[Epub]     CrossRef
  • Efficacy and Safety of Tetrabenazine in Reducing Chorea and Improving Motor Function in Individuals With Huntington's Disease: A Systematic Review
    Nandini Vadlamani, Sabina Ibrahimli, Farees Ahmad Khan, Jason A Castillo, Kavya Sai Satya Amaravadi, Poornachandra Nalisetty, Safeera Khan
    Cureus.2024;[Epub]     CrossRef
  • Neurofilament light chain: a biomarker at the crossroads of clarity and confusion for gene-directed therapies
    Michael Christian A Virata, Jesus Alfonso Catahay, Giuseppe Lippi, Brandon M Henry
    Neurodegenerative Disease Management.2024; 14(6): 227.     CrossRef
  • Positron Emission Tomography Quantitative Assessment of Off-Target Whole-Body Biodistribution of I-124-Labeled Adeno-Associated Virus Capsids Administered to Cerebral Spinal Fluid
    Jonathan B. Rosenberg, Edward K. Fung, Jonathan P. Dyke, Bishnu P. De, Howard Lou, James M. Kelly, Layla Reejhsinghani, Rodolfo J. Ricart Arbona, Dolan Sondhi, Stephen M. Kaminsky, Nathalie Cartier, Christian Hinderer, Juliette Hordeaux, James M. Wilson,
    Human Gene Therapy.2023;[Epub]     CrossRef
  • CRISPR: a tool with potential for genomic reprogramming in neurological disorders
    Yogesh K. Dhuriya, Aijaz A. Naik
    Molecular Biology Reports.2023; 50(2): 1845.     CrossRef
  • Gene therapy for selected neuromuscular and trinucleotide repeat disorders – An insight to subsume South Asia for multicenter clinical trials
    Nalaka Wijekoon, Lakmal Gonawala, Pyara Ratnayake, Darshana Sirisena, Harsha Gunasekara, Athula Dissanayake, Sunethra Senanayake, Ajantha Keshavaraj, Yetrib Hathout, Harry W.M. Steinbusch, Chandra Mohan, Ashwin Dalal, Eric Hoffman, K.Ranil D de Silva
    IBRO Neuroscience Reports.2023; 14: 146.     CrossRef
  • Huntington’s Disease Drug Development: A Phase 3 Pipeline Analysis
    Hannah J. Van de Roovaart, Nguyen Nguyen, Timothy D. Veenstra
    Pharmaceuticals.2023; 16(11): 1513.     CrossRef
  • Mitochondrial organization and structure are compromised in fibroblasts from patients with Huntington’s disease
    Marie Vanisova, Hana Stufkova, Michaela Kohoutova, Tereza Rakosnikova, Jana Krizova, Jiri Klempir, Irena Rysankova, Jan Roth, Jiri Zeman, Hana Hansikova
    Ultrastructural Pathology.2022; 46(5): 462.     CrossRef
  • Pathogenesis of Huntington’s Disease: An Emphasis on Molecular Pathways and Prevention by Natural Remedies
    Zainab Irfan, Sofia Khanam, Varnita Karmakar, Sayeed Mohammed Firdous, Bothaina Samih Ismail Abou El Khier, Ilyas Khan, Muneeb U. Rehman, Andleeb Khan
    Brain Sciences.2022; 12(10): 1389.     CrossRef
Brief communication
Clinical and Imaging Profile of Patients with Joubert Syndrome
Bharath Kumar Surisetti, Vikram Venkappayya Holla, Shweta Prasad, Koti Neeraja, Nitish Kamble, Ravi Yadav, Pramod Kumar Pal
J Mov Disord. 2021;14(3):231-235.   Published online September 16, 2021
DOI: https://doi.org/10.14802/jmd.21066
  • 8,653 View
  • 168 Download
  • 11 Web of Science
  • 10 Crossref
AbstractAbstract PDFSupplementary Material
Objective
Joubert syndrome (JS) is a rare syndrome characterized by ataxia and the molar tooth sign (MTS) on imaging. The present study aims to explore the clinical and radiological features in a cohort of patients with JS.
Methods
This was a retrospective chart review of patients with JS evaluated by movement disorder specialists.
Results
Nine patients were included in the study. All patients had facial dysmorphism and ocular abnormalities, and 4 patients had dystonia. Ocular tilt reaction and alternate skew deviation (66%) were the most common ocular abnormalities. Horizontally aligned superior cerebellar peduncles were observed in all four patients with diffusion tensor imaging, with a lack of decussation in three. Exome sequencing performed in four patients revealed novel variants in the MKS1, CPLANE1, and PIBF1 genes.
Conclusion
Facial dysmorphism, ocular abnormalities and classical imaging findings were observed in all patients with JS. Apart from ataxia, dystonia and myoclonus are other movement disorders observed in JS.

Citations

Citations to this article as recorded by  
  • A Novel Pathogenic Splicing Mutation of OFD1 is Responsible for a Boy with Joubert Syndrome Exhibiting Orofaciodigital Spectrum Anomalies, Polydactyly and Retinitis Pigmentosa
    Liang Chen, Mei-Fang Zhao, Hui-Wen Deng, Min Liao, Liang-Liang Fan, Qi-Bao Zhong, Jun Wang, Ke Li, Zheng-Hui Wu, Jian-Yin Yin
    Pharmacogenomics and Personalized Medicine.2025; Volume 18: 47.     CrossRef
  • Phenotypic Spectrum of KATNIP-Associated Joubert Syndrome: Possible Association with Esophageal Atresia and Review of the Literature
    Maria Giovanna Tedesco, Ilaria Donati, Chiara Romeo, Sara Dal Bo, Chiara Nardini, Anna Maria Innoceta, Giulia Parmeggiani, Anna Patanè, Claudio Graziano
    Genes.2025; 16(5): 524.     CrossRef
  • Joubert Sendromlu Hastanın Diş Tedavilerinde Anestezi Yönetimi: Olgu Sunumu
    Mehmet Akif Yılmaz, Feyza Şimşek, Havva Yavuz, Nuray Uzun, Murat Büyüksefil, Fatih Şengül, Elif Oral Ahıskalıoğlu
    Atatürk Üniversitesi Tıp Fakültesi Cerrahi Tıp Bilimleri Dergisi.2024; 3(1): 15.     CrossRef
  • Joubert Syndrome Presenting With Levodopa-Responsive Parkinsonism
    Jin Hwangbo, Ki-Seok Park, Hyun Sung Kim, Jae-Hwan Choi, Jae-Hyeok Lee
    Journal of Movement Disorders.2024; 17(3): 339.     CrossRef
  • Progressive Dysphagia in Joubert Syndrome: A Report of a Rare Case
    Courteney Castellano, Jomaries O Gomez Rosado, Alexandra Witt, Rebecca Simon, Dyadin Esharif
    Cureus.2024;[Epub]     CrossRef
  • A Novel Homozygous Variant in CPLANE1 Gene in a Patient with Developmental Deficits
    Bhagyalakshmi Shankarappa, Vishnu P. Prasad, Sujith Kumar, Ravi Shankar Rao, Angel Beula Royal, Mahadeva Swamy, Pannaga Prasad, Ashitha S. Niranjana Murthy, Suhas Ganesh, Biju Viswanath, Sanjeev Jain, Meera Purushottam, Murali Thyloth
    Molecular Syndromology.2024; : 1.     CrossRef
  • Novel PIBF1 Pathogenic Variant in Three Siblings with Joubert Syndrome Type 33
    Busra Aynekin, Bahadır M. Samur, Ummu Gulsum Ozgul Gumus, Kaya Bilguvar, Ayten Gulec, Stephanie Efthymiou, Hakan Gumus, Ahmet Okay Caglayan, Huseyin Per
    Molecular Syndromology.2024; 16(5): 411.     CrossRef
  • Clinical and genetic characteristics of 36 children with Joubert syndrome
    Yan Dong, Ke Zhang, He Yao, Tianming Jia, Jun Wang, Dengna Zhu, Falin Xu, Meiying Cheng, Shichao Zhao, Xiaoyi Shi
    Frontiers in Pediatrics.2023;[Epub]     CrossRef
  • CEP104 gene may involve in the pathogenesis of a new developmental disorder other than joubert syndrome
    Reza Shervin Badv, Mojdeh Mahdiannasser, Maryam Rasoulinezhad, Laleh Habibi, Ali Rashidi-Nezhad
    Molecular Biology Reports.2022; 49(8): 7231.     CrossRef
  • Congenital Brain Malformations: An Integrated Diagnostic Approach
    Bimal P. Chaudhari, Mai-Lan Ho
    Seminars in Pediatric Neurology.2022; 42: 100973.     CrossRef
Original Articles
Article image
Patient Knowledge, Attitude and Perceptions towards Botulinum Toxin Treatment for Movement Disorders in India
Thavasimuthu Nisha Mol, Nitish Kamble, Vikram V. Holla, Rohan Mahale, Pramod Kumar Pal, Ravi Yadav
J Mov Disord. 2021;14(2):126-132.   Published online April 26, 2021
DOI: https://doi.org/10.14802/jmd.20094
  • 7,326 View
  • 116 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract PDFSupplementary Material
Objective
There is limited literature on the knowledge, attitude, and perceptions (KAP) of botulinum toxin (BoNT) treatment among patients and caregivers. The objective of this study was to assess the KAP in patients undergoing BoNT treatment for movement disorders.
Methods
One hundred patients with movement disorders from National Institute of Mental Health and Neurosciences Hospital in Bengaluru, South India, were recruited. The patients underwent demographic, clinical, and Patient Knowledge Questionnaire on Botulinum Toxin Use in Movement Disorders (PKQ-BMD)-based evaluations.
Results
The mean age of patients at the time of presentation was 47.97 ± 14.19 years (range, 12–79). Of all the patients, 26 (28%) patients were anxious, and 86% of these patients were reassured after appropriate counseling. There were 83 (89%) patients who found BoNT to be a costlier option. Education and previous Internet searches influenced positive performance in the “knowledge” domain and overall PKQ-BMD scores. The “number of injections” was also positively correlated with KAP performance.
Conclusion
This study showed that knowledge and perceptions about BoNT treatment need to be further improved. Wider availability of the Internet has provided a positive impact on patients’ and carers’ KAP. Internet-based information, higher educational qualifications of the patients, and a higher number of BoNT injection sessions are the most important predictors of satisfactory KAP related to BoNT injection treatment in patients with movement disorders.

Citations

Citations to this article as recorded by  
  • Barriers to providing movement disorders care in India
    Heli Shah, Prashanth Lingappa Kukkle
    Current Opinion in Neurology.2025; 38(4): 361.     CrossRef
Article image
Telemedicine in an Academic Movement Disorders Center during COVID-19
Christine Doss Esper, Laura Scorr, Sosi Papazian, Daniel Bartholomew, Gregory Jacob Esper, Stewart Alan Factor
J Mov Disord. 2021;14(2):119-125.   Published online March 18, 2021
DOI: https://doi.org/10.14802/jmd.20099
  • 10,152 View
  • 155 Download
  • 20 Web of Science
  • 20 Crossref
AbstractAbstract PDF
Objective
Telemedicine has rapidly gained momentum in movement disorder neurology during the coronavirus disease (COVID-19) pandemic to preserve clinical care while mitigating the risks of in-person visits. We present data from the rapid implementation of virtual visits in a large, academic, movement disorder practice during the COVID-19 pandemic.
Methods
We describe the strategic shift to virtual visits and retrospectively examine elements that impacted the ability to switch to telemedicine visits using historical prepandemic in-person data as a comparator, including demographics, distance driven, and diagnosis distribution, with an additional focus on patients with deep brain stimulators.
Results
A total of 686 telemedicine visits were performed over a five-week period (60% of those previously scheduled for in-office visits). The average age of participants was 65 years, 45% were female, and 73% were Caucasian. Men were more likely to make the transition (p = 0.02). Telemedicine patients lived farther from the clinic than those seen in person (66.47 km vs. 42.16 km, p < 0.001), age was not associated with making the switch, and patient satisfaction did not change. There was a significant shift in the distribution of movement disorder diagnoses seen by telemedicine compared to prepandemic in-person visits (p < 0.001). Patients with deep brain stimulators were more likely to use telemedicine (11.5% vs. 7%, p < 0.001).
Conclusion
Telemedicine is feasible, viable and relevant in the care of movement disorder patients, although health care disparities appear evident for women and minorities. Patients with deep brain stimulators preferred telemedicine in our study. Further study is warranted to explore these findings.

Citations

Citations to this article as recorded by  
  • Accelerated symptom improvement in Parkinson’s disease via remote internet-based optimization of deep brain stimulation therapy: a randomized controlled multicenter trial
    Alireza Gharabaghi, Sergiu Groppa, Marta Navas-Garcia, Alfons Schnitzler, Laura Muñoz-Delgado, Vicky L. Marshall, Jessica Karl, Lin Zhang, Ramiro Alvarez, Mary S. Feldman, Michael J. Soileau, Lan Luo, S. Elizabeth Zauber, Benjamin L. Walter, Chengyuan Wu,
    Communications Medicine.2025;[Epub]     CrossRef
  • Telemedicine Experiences of People Living with Amyotrophic Lateral Sclerosis at Home in South Korea
    Min Sun Kim, Shin Hye Yoo, Kyae Hyung Kim, Belong Cho, Sun Young Lee
    Yonsei Medical Journal.2025; 66(6): 366.     CrossRef
  • Digital Inclusion in Parkinson's Disease: A Case–Control Study
    Vincenzo Canoro, Andrea Pilotto, Francesco Lena, Valentina Fioravanti, Chiara Longo, Tommaso Schirinzi, Marina Picillo, Maria Teresa Pellecchia, Cristiano Sorrentino, Francesco Cavallieri, Alessandro Padovani, Maria Chiara Malaguti, Nicola Modugno, Paolo
    Movement Disorders Clinical Practice.2025; 12(11): 1873.     CrossRef
  • Video-based telemedicine utilization patterns and associated factors among racial and ethnic minorities in the United States during the COVID-19 pandemic: A mixed-methods scoping review
    John M. Meddar, Ratnalekha V. N. Viswanadham, Defne L. Levine, Tiffany R. Martinez, Kendra Willis, Noah Choi, Jackson Douglas, Katharine S. Lawrence, Hadi Ghasemi
    PLOS Digital Health.2025; 4(7): e0000952.     CrossRef
  • Telemedicine Use Among Older Adults During COVID-19: A Narrative Literature Review of Utilization Patterns
    Meghan N. Breckling, Leah Tobey-Moore, Allie Parsons, Madeline Butera, Caraline Annichiarico, Mohab Ali
    Telemedicine Reports.2025; 6(1): 371.     CrossRef
  • Interest and Satisfaction of Telemedicine Use Among Ambulatory Neurology Patients in Western North Carolina During the COVID-19 Pandemic
    K. Alexander Soltany, Reyna Segovia Molina, Carly Pappo, Sharon Thomson, Kelly Pring, Siobhan Cox, Rebecca Merrill, Emily Fishman, Alexander Ambrosini, Gabby Bognet, Kristen Dodenhoff, Heidi Munger Clary, Lauren Strauss, Rachel Graham, Amy K. Guzik, Roy E
    Telemedicine and e-Health.2024; 30(4): e1071.     CrossRef
  • The Importance of Digital Health Literacy in an Evolving Parkinson’s Disease Care System
    Christine D. Esper, Blanca Y. Valdovinos, Ruth B. Schneider
    Journal of Parkinson’s Disease.2024; 14(s1): S181.     CrossRef
  • Neurological Examination via Telemedicine: An Updated Review Focusing on Movement Disorders
    Efthalia Angelopoulou, Christos Koros, Evangelia Stanitsa, Ioannis Stamelos, Dionysia Kontaxopoulou, Stella Fragkiadaki, John D. Papatriantafyllou, Evangelia Smaragdaki, Kalliopi Vourou, Dimosthenis Pavlou, Panagiotis D. Bamidis, Leonidas Stefanis, Sokrat
    Medicina.2024; 60(6): 958.     CrossRef
  • Long‐Lasting Impact of the COVID‐19 Pandemic on Patients with Parkinson's Disease and Their Relatives
    Andreas Wolfgang Wolff, Bernhard Haller, Antonia Franziska Demleitner, Dominik Pürner, Johanna Niederschweiberer, Isabell Cordts, Erica Westenberg, Paul Lingor
    Movement Disorders Clinical Practice.2023; 10(5): 819.     CrossRef
  • Telemedicine technologies and applications in the era of COVID-19 pandemic: A systematic review
    Esmaeil Mehraeen, SeyedAhmad SeyedAlinaghi, Mohammad Heydari, Amirali Karimi, Abdollah Mahdavi, Mehrnaz Mashoufi, Arezoo Sarmad, Peyman Mirghaderi, Ahmadreza Shamsabadi, Kowsar Qaderi, Pegah Mirzapour, Amirata Fakhfouri, Hadiseh Azadi Cheshmekabodi, Kimia
    Health Informatics Journal.2023;[Epub]     CrossRef
  • Racial disparities in access to DBS: results of a real-world U.S. claims data analysis
    Michael Frassica, Drew S. Kern, Mitra Afshari, Allison T. Connolly, Chengyuan Wu, Nathan Rowland, Juan Ramirez-Castaneda, Mwiza Ushe, Claudia Salazar, Xenos Mason
    Frontiers in Neurology.2023;[Epub]     CrossRef
  • Parkinson’s disease patients’ perspective on telephone visits during the COVID-19 pandemic
    Marta Magriço, Miguel Serôdio, Rita Ventura, Paulo Bugalho
    Journal of Neural Transmission.2023; 130(12): 1547.     CrossRef
  • Telemedicine in Neurology: A Scoping Review of Key Outcomes in Movement Disorders
    Emily Houston, Amanda G. Kennedy, Donna O'Malley, Terry Rabinowitz, Gail L. Rose, James Boyd
    Telemedicine and e-Health.2022; 28(3): 295.     CrossRef
  • Clinician and patient experience of neurology telephone consultations during the COVID-19 pandemic
    Tagore Nakornchai, Elena Conci, Anke Hensiek, J William L Brown
    Postgraduate Medical Journal.2022; 98(1161): 533.     CrossRef
  • Moving Forward from the COVID-19 Pandemic: Needed Changes in Movement Disorders Care and Research
    B. Y. Valdovinos, J. S. Modica, R. B. Schneider
    Current Neurology and Neuroscience Reports.2022; 22(2): 113.     CrossRef
  • Movement Disorder Specialists Survey Regarding Use of Telemedicine During the COVID-19 Pandemic
    Shadi Ghourchian, Yasar A. Torres-Yaghi, Stuart H. Isaacson, Fernando Pagan, Kelly E. Lyons, Brian James Nagle, Sanskruti Patel, Rajesh Pahwa
    Telemedicine and e-Health.2022; 28(11): 1651.     CrossRef
  • Attitudes Toward Telehealth Services Among People Living With Parkinson's Disease: A Survey Study
    Yaqian Xu, Megan P. Feeney, Matthew Surface, Dan Novak, Michelle S. Troche, James C. Beck, Roy N. Alcalay
    Movement Disorders.2022; 37(6): 1289.     CrossRef
  • Service process factors affecting patients’ and clinicians’ experiences on rapid teleconsultation implementation in out-patient neurology services during COVID-19 pandemic: a scoping review
    Guangxia Meng, Carrie McAiney, Christopher M. Perlman, Ian McKillop, Therese Tisseverasinghe, Helen H. Chen
    BMC Health Services Research.2022;[Epub]     CrossRef
  • Telemedicine in the Management of Parkinson’s Disease: Achievements, Challenges, and Future Perspectives
    Esther Cubo, Pedro David Delgado-López
    Brain Sciences.2022; 12(12): 1735.     CrossRef
  • Clinician Perceptions of the Negative Impact of Telehealth Services in the Management of Drug-Induced Movement Disorders and Opportunities for Quality Improvement: A 2021 Internet-Based Survey
    Rimal Bera, Morgan Bron, Betsy Benning, Samantha Cicero, Heintje Calara, Diane Darling, Ericha Franey, Kendra Martello, Charles Yonan
    Neuropsychiatric Disease and Treatment.2022; Volume 18: 2945.     CrossRef
Clinical Characteristics of Involuntary Movement in Hospitalized Patients
Kyum-Yil Kwon, Hye Mi Lee, Seon-Min Lee, Seong-Beom Koh
J Mov Disord. 2019;12(1):31-36.   Published online December 20, 2018
DOI: https://doi.org/10.14802/jmd.18040
  • 9,899 View
  • 237 Download
  • 2 Web of Science
  • 2 Crossref
AbstractAbstract PDF
Objective
Neurological symptoms in hospitalized patients are not rare, and neurological consultation for movement disorders is especially important in evaluating or managing those with various movement disorders. Therefore, we investigated a clinical pattern of in-hospital consultations for various movement disorders in a tertiary care university hospital.
Methods
Over two years, a total of 202 patients (70.7 ± 11.8 years of age) presenting with movement disorders referred to movement disorder specialists were investigated.
Results
The main symptoms referred by nonneurologists were tremor (56.9%), parkinsonism (16.8%), and gait disturbance (8.9%). The most frequent diagnostic category was toxic/metabolic-caused movement disorder (T/MCMD) (35%) with regard to medications, followed by Parkinson’s disease (PD) (16%). Regarding the mode of onset, T/MCMD was the leading cause for acute (68%) and subacute onset (46%), while PD was the leading disorder (31%) for chronic onset.
Conclusion
The current study showed a characteristic pattern of inpatients presenting with movement disorders. Furthermore, our findings highlighted the clinical significance of drug use or metabolic problems for treating this patient population.

Citations

Citations to this article as recorded by  
  • Pattern and frequency of involuntary movements: hospital-based study
    H. N. El Tallawy, A. S. Shalash, M. A. Abdelhamed, R. E. Elsabrout
    The Egyptian Journal of Neurology, Psychiatry and Neurosurgery.2023;[Epub]     CrossRef
  • Clinical Spectrum of Movement Disorders in Neurology Inpatients in a Tertiary Care Centre
    Shabeer Ahmad Paul, Gouranga Prasad Mondal, Ramesh Bhattacharyya, Kartik Chandra Ghosh, Sarbajit Das, Suman Das, Hema Krishna, Chandrakanta Patra
    Journal of Neurosciences in Rural Practice.2021; 12: 581.     CrossRef
Oromandibular Dystonia: Demographics and Clinical Data from 240 Patients
Linda Slaim, Myriam Cohen, Patrick Klap, Marie Vidailhet, Alain Perrin, Daniel Brasnu, Denis Ayache, Marie Mailly
J Mov Disord. 2018;11(2):78-81.   Published online May 30, 2018
DOI: https://doi.org/10.14802/jmd.17065
  • 10,767 View
  • 260 Download
  • 25 Web of Science
  • 30 Crossref
AbstractAbstract PDF
Objective
To report demographic data from a large cohort of patients with oromandibular dystonia (OMD).
Methods
This is a retrospective review of patients with OMD referred to our institution between 1989 and 2015. Demographic (age of onset, gender, and familial history of dystonia) and clinical (type of OMD, associated dystonia, and etiology of dystonia) data were collected from a cohort of 240 individuals.
Results
The mean age of onset of OMD was 51.6 years old, with a female predominance (2:1). A family history of dystonia was found in 6 patients (2.5%). One hundred and forty-nine patients (62.1%) had the jaw-opening type of OMD, 48 patients (20.0%) had the jaw-closing type, and 43 patients (17.9%) had a mixed form of OMD. Lingual dystonia was also present in 64 (26.7%) of these patients. Eighty-two patients (34.2%) had a focal dystonia, 131 patients (54.6%) had a segmental dystonia, and 27 patients (11.3%) had a generalized dystonia. One hundred and seventy-one patients (71.3%) had idiopathic OMD.
Conclusion
OMD is a chronic and disabling focal dystonia. Our study found a prevalence of female patients, an onset in middle age and a predominantly idiopathic etiology. Unlike other studies, jaw-opening was found to be the most frequent clinical type of OMD.

Citations

Citations to this article as recorded by  
  • Application of surface electromyography in dentistry for diagnosis and treatment evaluation
    So Ra Kim, Yeong-Gwan Im
    Journal of Korean Dental Association.2025; 63(3): 64.     CrossRef
  • Measurement of Disease Comorbidity Using Semantic Profiling of Disease Genes
    Seong Beom Cho
    International Journal of Molecular Sciences.2025; 26(8): 3906.     CrossRef
  • Surface electromyography for evaluating patients with oromandibular dystonia
    Jae-Hyung Kim, Byung-Gook Kim, Yeong-Gwan Im
    CRANIO®.2024; 42(3): 316.     CrossRef
  • Tongue dystonia as CIS and presenting symptom of multiple sclerosis
    Farid Shamlou, Narges Ebrahimi, Ahmad Chitsaz
    Neuroimmunology Reports.2024; 5: 100191.     CrossRef
  • Oromandibular dystonia: from onset to spread a multicenter italian study
    Assunta Trinchillo, Marcello Esposito, Carmen Terranova, Vincenzo Rizzo, Giovanni Fabbrini, Gina Ferrazzano, Daniele Belvisi, Roberto Erro, Paolo Barone, Francesco Bono, Francesca Di Biasio, Anna Rita Bentivoglio, Christian Lettieri, Maria Concetta Altavi
    Neurological Sciences.2024; 45(9): 4341.     CrossRef
  • A Case Study of Korean Medicine Treatment in a Patient Complaining of Generalized Dystonia
    Kyeong-hwa Lee, Hye-min Heo, Dong-joo Kim, Min-jae Kwak, Ye-chae Hwang, Seung-yeon Cho, Jung-mi Park, Chang-nam Ko, Seong-uk Park
    The Journal of Internal Korean Medicine.2024; 45(2): 208.     CrossRef
  • Treatment with OnabotulinumtoxinA for Oromandibular Dystonia: A Systematic Review and Meta-Analysis
    Kazuya Yoshida, Ryuji Kaji
    Toxins.2024; 16(12): 546.     CrossRef
  • Oromandibular Dystonia: Clinical and Demographic Data from Eight-Two Patients
    Mehmet Balal, Meltem Demirkiran
    Tremor and Other Hyperkinetic Movements.2023;[Epub]     CrossRef
  • Oromandibular Dystonia is a Prominent Feature in Patients with Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency
    Helio van der Linden Jr., Christiane Cobas, Andre Felipe Pinto Duarte, Marcelo Rodrigues Masruha
    Journal of Inborn Errors of Metabolism and Screening.2023;[Epub]     CrossRef
  • Clinical Presentation and Management of Peripheral-induced Oromandibular Dystonia in Nigeria: A Case Report and Literature Update
    Nonso Emmanuel Onyia, Mercy Okoh, Obinna Francis Igwilo, Izegboya Vivian Ukpebor, Eze Stephen Nwauzor
    Nigerian Journal of Medicine.2023; 32(4): 433.     CrossRef
  • Oromandibular Dystonia – A Systematic Review
    Udit Saraf, Mitesh Chandarana, K. P Divya, Syam Krishnan
    Annals of Indian Academy of Neurology.2022; 25(1): 26.     CrossRef
  • Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System
    Kazuya Yoshida
    Toxins.2022; 14(4): 282.     CrossRef
  • Botulinum toxin injections in jaw-opening dystonia. The lateral pterygoid – maxillary artery problem
    Sena Ünal, F. Tugra Karaarslan-Turk, Muhittin Cenk Akbostanci, Elif Peker, Rezzak Yilmaz
    Journal of Clinical Neuroscience.2022; 101: 217.     CrossRef
  • Oromandibular dystonia seen during pramipexole treatment: A rare case
    Fatma KARA, Mehmet Fatih GÖL, Ayhan VARLIBAŞ
    Journal of Surgery and Medicine.2022; 6(6): 1.     CrossRef
  • Dystonia, chorea, hemiballismus and other dyskinesias
    Matteo Bologna, Josep Valls-Solè, Nitish Kamble, Pramod Kumar Pal, Antonella Conte, Andrea Guerra, Daniele Belvisi, Alfredo Berardelli
    Clinical Neurophysiology.2022; 140: 110.     CrossRef
  • Movement disorders of the mouth: a review of the common phenomenologies
    C. M. Ghadery, L. V. Kalia, B. S. Connolly
    Journal of Neurology.2022; 269(11): 5812.     CrossRef
  • Botulinum Toxin in Movement Disorders: An Update
    Charenya Anandan, Joseph Jankovic
    Toxins.2021; 13(1): 42.     CrossRef
  • Temporomandibular disorder–related characteristics and treatment outcomes in Oromandibular Dystonia patients in two different clinical settings: A cross‐sectional study
    Asha Sude, Joseph Matsumoto, Shanti Kaimal, Ashley Petersen, Donald R. Nixdorf
    Journal of Oral Rehabilitation.2021; 48(5): 542.     CrossRef
  • Jaw Pain and Oromandibular Dysfunction After a Complex Hospital Course
    Sarah Smith, Ny-Ying Lam
    American Journal of Physical Medicine & Rehabilitation.2021; 100(5): e62.     CrossRef
  • Oromandibular Dystonia: A Clinical Examination of 2,020 Cases
    Laura M. Scorr, Stewart A. Factor, Sahyli Perez Parra, Rachel Kaye, Randal C. Paniello, Scott A. Norris, Joel S. Perlmutter, Tobias Bäumer, Tatiana Usnich, Brian D. Berman, Marie Mailly, Emmanuel Roze, Marie Vidailhet, Joseph Jankovic, Mark S. LeDoux, Ric
    Frontiers in Neurology.2021;[Epub]     CrossRef
  • Evaluation of Treatment Outcomes in Oromandibular Dystonia Using Surface Electromyography: A Case Series
    Yeong-Gwan Im, Jae-Hyung Kim, Byung-Gook Kim
    Journal of Oral Medicine and Pain.2021; 46(4): 143.     CrossRef
  • Application of botulinum toxin in pregnancy and its impact on female reproductive health
    Wu Li, Min Tang
    Expert Opinion on Drug Safety.2020; 19(1): 83.     CrossRef
  • Prevalence and clinical characteristics of patients with oromandibular dystonia seen in the orofacial pain clinic: a retrospective study
    Asha Sude, Donald R. Nixdorf
    Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.2020; 130(2): 169.     CrossRef
  • Clinical spectrum of focal dystonias: Experience from a tertiary care center
    Rupesh Prasad, Deepika Joshi, VijayN Mishra, RameshwarN Chaurasia, Abhishek Pathak
    Annals of Movement Disorders.2020; 3(2): 99.     CrossRef
  • Bite injury related to oromandibular dystonia extending to the maxillary sinus: A case report
    Yoshiro Koma, Takehiro Fujimoto, Shinji Uejima, Kotaro Sato, Keisuke Sugimoto, Satoshi Yamaguchi, Jun Ishikawa, Kazuya Nambu, Hideharu Hibi
    Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology.2020; 32(6): 503.     CrossRef
  • Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis
    Pariessa D. Dadgardoust, Raymond L. Rosales, Ria Monica Asuncion, Dirk Dressler
    Journal of Neural Transmission.2019; 126(2): 141.     CrossRef
  • Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features
    Kazuya Yoshida
    Toxins.2019; 11(1): 51.     CrossRef
  • Oromandibular dystonia, mental distress and oro‐facial dysfunction—A follow‐up 8‐10 years after start of treatment with botulinum toxin
    Merete Bakke, Sara Baram, Torben Dalager, Heidi Bryde Biernat, Eigild Møller
    Journal of Oral Rehabilitation.2019; 46(5): 441.     CrossRef
  • Pseudodystonia: A new perspective on an old phenomenon
    Rok Berlot, Kailash P. Bhatia, Maja Kojović
    Parkinsonism & Related Disorders.2019; 62: 44.     CrossRef
  • Severe Jaw‐Opening Dystonia as an Unusual Manifestation of Levodopa‐Related Wearing‐Off in Parkinson's Disease, and Successful Treatment With Botulinum Toxin Injection
    Pankaj Ashok Agarwal
    Movement Disorders Clinical Practice.2019; 6(6): 500.     CrossRef
Case Report
Paroxysmal Kinesigenic Dyskinesia as the Presenting and Only Manifestation of Multiple Sclerosis after Eighteen Months of Follow-Up
Marius Baguma, Michel Ossemann
J Mov Disord. 2017;10(2):96-98.   Published online March 24, 2017
DOI: https://doi.org/10.14802/jmd.16055
  • 13,602 View
  • 196 Download
  • 7 Web of Science
  • 8 Crossref
AbstractAbstract PDF
Other than tremor, movement disorders are uncommon in multiple sclerosis. Among these uncommon clinical manifestations, paroxysmal kinesigenic dyskinesia is the most frequently reported. It is characterized by episodic attacks of involuntary movements that are induced by repetitive or sudden movements, startling noise or hyperventilation. The diagnosis is essentially clinical and based on a good observation of the attacks. It is very easy to misdiagnose it. We describe the case of a young female patient who presented paroxysmal kinesigenic dyskinesia as the first and only clinical manifestation of multiple sclerosis, with no recurrence of attacks nor any other neurologic symptom after eighteen months of follow-up.

Citations

Citations to this article as recorded by  
  • Evaluating the Performance of In Silico Tools for PRRT2 Missense Variants
    Hui Sun, Wang Song, Bin Li
    Combinatorial Chemistry & High Throughput Screening.2025; 28(11): 1965.     CrossRef
  • Painful Paroxysmal Dystonia as a Revealing Symptom of Multiple Sclerosis: A Case Report and Literature Review
    Fatima Ez-Zahra Mabrouki, Samah Yousfi, Sanae Elhasnaoui, Yassine Mebrouk
    Cureus.2025;[Epub]     CrossRef
  • Tongue dystonia as CIS and presenting symptom of multiple sclerosis
    Farid Shamlou, Narges Ebrahimi, Ahmad Chitsaz
    Neuroimmunology Reports.2024; 5: 100191.     CrossRef
  • The Pathogenesis of Paroxysmal Kinesigenic Dyskinesia: Current Concepts
    Zi‐yi Li, Wo‐tu Tian, Xiao‐jun Huang, Li Cao
    Movement Disorders.2023; 38(4): 537.     CrossRef
  • Movement Disorder in Demyelinating Disease
    Rashmi Singh, Sanjay Pandey
    Annals of Indian Academy of Neurology.2022; 25(5): 821.     CrossRef
  • Recommendations for the diagnosis and treatment of paroxysmal kinesigenic dyskinesia: an expert consensus in China
    Li Cao, Xiaojun Huang, Ning Wang, Zhiying Wu, Cheng Zhang, Weihong Gu, Shuyan Cong, Jianhua Ma, Ling Wei, Yanchun Deng, Qi Fang, Qi Niu, Jin Wang, Zhaoxia Wang, You Yin, Jinyong Tian, Shufen Tian, Hongyan Bi, Hong Jiang, Xiaorong Liu, Yang Lü, Meizhen Sun
    Translational Neurodegeneration.2021;[Epub]     CrossRef
  • Les mouvements anormaux : mise au point
    M. Béreau, C. Tranchant
    La Revue de Médecine Interne.2018; 39(8): 641.     CrossRef
  • Lesion correlates of secondary paroxysmal dyskinesia in multiple sclerosis
    Kilian Fröhlich, Klemens Winder, Ralf A. Linker, Konstantin Huhn, Tobias Engelhorn, Arnd Dörfler, De-Hyung Lee, Stefan Schwab, Frank Seifert
    Journal of Neurology.2018; 265(10): 2277.     CrossRef
Original Article
Psychodynamic Psychotherapy for Functional (Psychogenic) Movement Disorders
Vibhash D. Sharma, Randi Jones, Stewart A. Factor
J Mov Disord. 2017;10(1):40-44.   Published online December 27, 2016
DOI: https://doi.org/10.14802/jmd.16038
  • 15,491 View
  • 212 Download
  • 17 Web of Science
  • 17 Crossref
AbstractAbstract PDF
Objective
As the literature for the treatment of functional (psychogenic) movement disorders (FMD) is sparse, we assessed clinical outcomes in patients with FMD who underwent treatment with psychodynamic psychotherapy (PDP).
Methods
A retrospective analysis of the data of patients with FMD who were referred for PDP from 2008−2014 at Emory University Medical Center was performed.
Results
Thirty patients were included, mean age at presentation was 50 years (SD 13.9) and majority were female (27/30). Most common movement disorder was involuntary shaking/jerky movements (50%) and tremor (43%). Mean duration of symptoms was 3.2 years and mean number of PDP visits was 4.9. PDP lead to good outcomes in 10, modest in 8, and poor in 9. Three patients lost to follow up. Mean duration of symptoms between two groups (good vs. poor) was not statistically significant (p = 0.11), mean number of PDP visits showed a trend towards significance (p = 0.053). In all cases of good outcomes precipitants of the movement disorder were identified and a majority (60%) was receptive of the diagnosis and had good insight.
Conclusion
PDP lead to improvement in 60% of the patients which is encouraging as the treatment is challenging. This study supports heterogeneous causes of FMD including varied roles of past/recent events and demonstrates importance of psychological approaches such as PDP. Treatment with PDP should be considered in some patients with FMD but predicting who will respond remains a challenge. Further long term prospective studies with large sample size and placebo control are needed.

Citations

Citations to this article as recorded by  
  • Cognitive reappraisal training as an intervention in patients with functional movement disorders: a placebo-controlled EEG pilot study
    Melanie Suette, Petra Schwingenschuh, Daniela Kern, Birgit Ludwig, Lukas Gattermeyer-Kell, Mariella Kögl, Maria Zangl, Corinna M. Perchtold-Stefan
    Journal of Neural Transmission.2026;[Epub]     CrossRef
  • Integrated model of care for functional movement disorder: targeting brain, mind and body
    Haseel Bhatt, Lindsey MacGillivray, Gabriela S. Gilmour, Keschey Marcelle, Laura Langer, Sarah C. Lidstone
    Disability and Rehabilitation.2025; 47(6): 1433.     CrossRef
  • Functional neurological disorder treated with psychoeducation: A case report
    Amal Yousef Alhazmi, Ahmed Ahmed Attar, Suhail Ali Labban, Reema Ghazi Felemban
    Medicine.2025; 104(3): e41194.     CrossRef
  • Tolerating Uncertainty as a Transdiagnostic Construct and Treatment Target in Functional Motor Disorder
    Beth K Rush, Katie J Traver, Elizabeth N Geissler, Mariah K Travis, Barbara Lubrano di Ciccone, Margaret A Moutvic-Wasz, Mohit Chauhan
    NeuroRehabilitation: An International, Interdisciplinary Journal.2025;[Epub]     CrossRef
  • Functional Tremor
    Kartika Gulati, Sanjay Pandey
    Seminars in Neurology.2025;[Epub]     CrossRef
  • Functional Tic‐Like Behaviors: A Common Comorbidity in Patients with Tourette Syndrome
    Kirsten R. Müller‐Vahl, Anna Pisarenko, Carolin Fremer, Martina Haas, Ewgeni Jakubovski, Natalia Szejko
    Movement Disorders Clinical Practice.2024; 11(3): 227.     CrossRef
  • Living with functional movement disorders: a tale of three battles. An interpretative phenomenological analysis
    Sylwia Bazydlo, Fiona J. R. Eccles
    Psychology & Health.2024; 39(8): 1130.     CrossRef
  • Neuropsychiatric Treatment Approaches for Functional Neurological Disorder: A How to Guide
    Sara A. Finkelstein, Caitlin Adams, Margaret Tuttle, Aneeta Saxena, David L. Perez
    Seminars in Neurology.2022; 42(02): 204.     CrossRef
  • Functional tremor
    Petra Schwingenschuh, Alberto J. Espay
    Journal of the Neurological Sciences.2022; 435: 120208.     CrossRef
  • Psychological interventions for treating functional motor symptoms: A systematic scoping review of the literature
    Erin M. Beal, Peter Coates, Cara Pelser
    Clinical Psychology Review.2022; 94: 102146.     CrossRef
  • Management of Functional Seizures and Functional Movement Disorder: A Cross-Sectional Comparative Study
    Bruno Gabriel Dal Pasquale, Hélio Afonso Ghizoni Teive, Marcelo Daudt von der Heyde, Luana Francine Anad Dal Pasquale
    Neuropsychiatric Disease and Treatment.2022; Volume 18: 2121.     CrossRef
  • Efficacy of a 5-day, intensive, multidisciplinary, outpatient physical and occupational therapy protocol in the treatment of functional movement disorders: A retrospective study
    Megan Reid, Steven D. Mitchell, Katharine M. Mitchell, Christos Sidiropoulos
    Journal of the Neurological Sciences.2022; 443: 120461.     CrossRef
  • Diagnosis and therapy of functional tremor a systematic review illustrated by a case report
    Michael Bartl, Rebekka Kewitsch, Mark Hallett, Martin Tegenthoff, Walter Paulus
    Neurological Research and Practice.2020;[Epub]     CrossRef
  • Speech, language and swallowing impairments in functional neurological disorder: a scoping review
    Caroline Barnett, Jean Armes, Christina Smith
    International Journal of Language & Communication Disorders.2019; 54(3): 309.     CrossRef
  • Functional movement disorders in neurogeriatric inpatients
    Sara Mätzold, Johanna Geritz, Kirsten E. Zeuner, Daniela Berg, Steffen Paschen, Johanne Hieke, Simone Sablowsky, Christian Ortlieb, Philipp Bergmann, Werner Hofmann, Alberto J. Espay, Walter Maetzler
    Zeitschrift für Gerontologie und Geriatrie.2019; 52(4): 324.     CrossRef
  • Psychogenic (Functional) Movement Disorders
    Mary Ann Thenganatt, Joseph Jankovic
    Continuum.2019; 25(4): 1121.     CrossRef
  • Disentangling Stigma from Functional Neurological Disorders: Conference Report and Roadmap for the Future
    Karen S. Rommelfanger, Stewart A. Factor, Suzette LaRoche, Phyllis Rosen, Raymond Young, Mark H. Rapaport
    Frontiers in Neurology.2017;[Epub]     CrossRef
Review Articles
Applications of CRISPR/Cas9 for Gene Editing in Hereditary Movement Disorders
Wooseok Im, Jangsup Moon, Manho Kim
J Mov Disord. 2016;9(3):136-143.   Published online September 21, 2016
DOI: https://doi.org/10.14802/jmd.16029
  • 25,808 View
  • 664 Download
  • 17 Web of Science
  • 13 Crossref
AbstractAbstract PDF
Gene therapy is a potential therapeutic strategy for treating hereditary movement disorders, including hereditary ataxia, dystonia, Huntington’s disease, and Parkinson’s disease. Genome editing is a type of genetic engineering in which DNA is inserted, deleted or replaced in the genome using modified nucleases. Recently, clustered regularly interspaced short palindromic repeat/CRISPR associated protein 9 (CRISPR/Cas9) has been used as an essential tool in biotechnology. Cas9 is an RNA-guided DNA endonuclease enzyme that was originally associated with the adaptive immune system of Streptococcus pyogenes and is now being utilized as a genome editing tool to induce double strand breaks in DNA. CRISPR/Cas9 has advantages in terms of clinical applicability over other genome editing technologies such as zinc-finger nucleases and transcription activator-like effector nucleases because of easy in vivo delivery. Here, we review and discuss the applicability of CRISPR/Cas9 to preclinical studies or gene therapy in hereditary movement disorders.

Citations

Citations to this article as recorded by  
  • A review of treatment methods for movement disorders
    Mahdi Khezri, Shakiba Afsar
    Behavioural Brain Research.2026; 500: 115979.     CrossRef
  • Effects of Electroporation Timing and Cumulus Cell Attachment on In Vitro Development and Genome Editing of Porcine Embryos
    Nanaka Torigoe, Qingyi Lin, Bin Liu, Yuichiro Nakayama, Aya Nakai, Megumi Nagahara, Fuminori Tanihara, Maki Hirata, Takeshige Otoi
    Reproduction in Domestic Animals.2025;[Epub]     CrossRef
  • CRISPR/Cas System: A Powerful Strategy to Improve Monogenic Human Diseases as Therapeutic Delivery; Current Applications and Challenges
    Fatemeh Saberi, Zeinab Yousefi-Najafabadi, Forough Shams, Zeinab Dehghan, Sepideh Ahmadi, Tayyebeh Pilehchi, Effat Noori, Zeinab Esmaeelzadeh, Maryam Bazgiri, Rezvan Mohammadi, Farzaneh Khani, Marzieh Sameni, Parisa Moradbeigi, Gholam Ali Kardar, Mohammad
    Current Gene Therapy.2025; 25(5): 663.     CrossRef
  • Current Status and Future Perspectives on Stem Cell-Based Therapies for Parkinson’s Disease
    Young Cha, Tae-Yoon Park, Pierre Leblanc, Kwang-Soo Kim
    Journal of Movement Disorders.2023; 16(1): 22.     CrossRef
  • Crispr-a novel approach towards a fortified immune system
    Vasudevan Ranganathan, Padma Madham, Prerana Shankpal, Charitha Sheri
    Journal of Microbiology & Experimentation.2023; 11(3): 73.     CrossRef
  • Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases
    Della Grace Thomas Parambi, Khalid Saad Alharbi, Rajesh Kumar, Seetha Harilal, Gaber El-Saber Batiha, Natália Cruz-Martins, Omnia Magdy, Arafa Musa, Dibya Sundar Panda, Bijo Mathew
    Molecular Neurobiology.2022; 59(1): 191.     CrossRef
  • Effects of the timing of electroporation during in vitro maturation on triple gene editing in porcine embryos using CRISPR/Cas9 system
    Zhao Namula, Manita Wittayarat, Lanh Thi Kim Do, Thanh Van Nguyen, Qingyi Lin, Koki Takebayashi, Maki Hirata, Fuminori Tanihara, Takeshige Otoi
    Veterinary and Animal Science.2022; 16: 100241.     CrossRef
  • Will CRISPR-Cas9 Have Cards to Play Against Cancer? An Update on its Applications
    Precilla S. Daisy, Kuduvalli S. Shreyas, T. S. Anitha
    Molecular Biotechnology.2021; 63(2): 93.     CrossRef
  • The significance of bioengineered nanoplatforms against SARS-CoV-2: From detection to genome editing
    Parichehr Hassanzadeh
    Life Sciences.2021; 274: 119289.     CrossRef
  • CRISPR/Cas9 Technology as a Modern Genetic Manipulation Tool for Recapitulating of Neurodegenerative Disorders in Large Animal Models
    Mahdi Barazesh, Shiva Mohammadi, Yadollah Bahrami, Pooneh Mokarram, Mohammad Hossein Morowvat, Massoud Saidijam, Morteza Karimipoor, Soudabeh Kavousipour, Amir Reza Vosoughi, Korosh Khanaki
    Current Gene Therapy.2021; 21(2): 130.     CrossRef
  • La edición del ADN
    Ithzayana Madariaga-Perpiñan, Juan Camilo Duque-Restrepo, Paola Ayala-Ramirez, Reggie García-Robles
    Iatreia.2020; 33(3): 262.     CrossRef
  • Mucuna pruriens in Parkinson’s and in some other diseases: recent advancement and future prospective
    Sachchida Nand Rai, Vivek K. Chaturvedi, Payal Singh, Brijesh Kumar Singh, M. P. Singh
    3 Biotech.2020;[Epub]     CrossRef
  • Current Approaches to the Treatment of Hunter Syndrome
    Ekaterina Yu. Zakharova, Elena Yu. Voskoboeva, Alla N. Semyachkina, Nato D. Vashakmadze, Amina I. Gamzatova, Svetlana V. Mikhailova, Sergey I. Kutsev
    Pediatric pharmacology.2018; 15(4): 324.     CrossRef
Movement Disorders Following Cerebrovascular Lesions: Etiology, Treatment Options and Prognosis
Do-Young Kwon
J Mov Disord. 2016;9(2):63-70.   Published online May 25, 2016
DOI: https://doi.org/10.14802/jmd.16008
  • 29,382 View
  • 818 Download
  • 9 Web of Science
  • 12 Crossref
AbstractAbstract PDF
Post-stroke movement disorders are uncommon, but comprise an important part of secondary movement disorders. These exert variable and heterogeneous clinical courses according to the stroke lesion and its temporal relationships. Moreover, the predominant stroke symptoms hinder a proper diagnosis in clinical practice. This article describes the etiology, treatment options and prognosis of post-stroke movement disorders.

Citations

Citations to this article as recorded by  
  • Cerebral hypoperfusion-related hemichorea: A case report and literature review
    Jia Shen, Quanzeng Zhang, Fanya Sun, Rong Li, Le Ding, Bo Zhu, Fang Yong, Zhiqin Liu, Naibing Gu, Zhengli Di
    Medicine.2025; 104(23): e42656.     CrossRef
  • Post-stroke movement disorders disappearance: a report of disappearance of tardive dyskinesia after stroke and a literature review
    Min Seung Kim, InJa Shin, Don Gueu Park, Jung han Yoon
    Acta Neurologica Belgica.2023; 123(5): 2005.     CrossRef
  • Monochorea after acute contralateral pontine infarction: A case report
    Yun Su Hwang, Byoung-Soo Shin, Han Uk Ryu, Hyun Goo Kang
    Medicine.2023; 102(3): e32660.     CrossRef
  • Adult-onset sporadic chorea: real-world data from a single-centre retrospective study
    Roberta Bovenzi, Matteo Conti, Rocco Cerroni, Mariangela Pierantozzi, Alessandro Stefani, Antonio Pisani, Nicola Biagio Mercuri, Tommaso Schirinzi
    Neurological Sciences.2022; 43(1): 387.     CrossRef
  • Parkinsonism and ataxia
    Giulia Franco, Giulia Lazzeri, Alessio Di Fonzo
    Journal of the Neurological Sciences.2022; 433: 120020.     CrossRef
  • Movement Disorders Associated With Cerebral Artery Stenosis: A Nationwide Study
    Kye Won Park, Nari Choi, Eungseok Oh, Chul Hyoung Lyoo, Min Seok Baek, Han-Joon Kim, Dalla Yoo, Jee-Young Lee, Ji-Hyun Choi, Jae Hyeok Lee, Seong-Beom Koh, Young Hee Sung, Jin Whan Cho, Hui-Jun Yang, Jinse Park, Hae-Won Shin, Tae-Beom Ahn, Ho-Sung Ryu, So
    Frontiers in Neurology.2022;[Epub]     CrossRef
  • Post-stroke Movement Disorders
    Priyanka Tater, Sanjay Pandey
    Neurology India.2021; 69(2): 272.     CrossRef
  • Hemibalismo y hemicorea secundarios a un ataque cerebrovascular isquémico insular, una presentación inusual: reporte de caso
    Carlos Martínez-Rubio, Hellen Kreinter-Rosenbaum, Habib Moutran-Barroso
    Neurología Argentina.2020; 12(3): 207.     CrossRef
  • Hemiballismus in subcortical lacunar infarcts
    ChinyeluUchenna Ufoaroh, OvercomerNnaemeka Agah, Nnamdi Morah, ErnestNdukaife Anyabolu
    Nigerian Journal of Medicine.2020; 29(3): 527.     CrossRef
  • COVID-19 and stroke: Red flags for secondary movement disorders?
    Daniella Balduino Victorino, Marcia Guimarães-Marques, Mariana Nejm, Fulvio Alexandre Scorza, Carla Alessandra Scorza
    eNeurologicalSci.2020; 21: 100289.     CrossRef
  • Post-stroke restless arm syndrome mimicking hemichorea–hemiballism
    Ha-yom Kim, Moon-Ho Park, Do-Young Kwon
    Acta Neurologica Belgica.2017; 117(3): 791.     CrossRef
  • Vascular Pathology Causing Late Onset Generalized Chorea: A Clinico‐Pathological Case Report
    Paula Salgado, Ricardo Taipa, Joana Domingos, Daniel Dias, Manuel Melo Pires, Marina Magalhães
    Movement Disorders Clinical Practice.2017; 4(6): 819.     CrossRef
Movement Disorders Following Cerebrovascular Lesion in the Basal Ganglia Circuit
Jinse Park
J Mov Disord. 2016;9(2):71-79.   Published online May 25, 2016
DOI: https://doi.org/10.14802/jmd.16005
  • 39,710 View
  • 1,109 Download
  • 61 Web of Science
  • 65 Crossref
AbstractAbstract PDF
Movement disorders are primarily associated with the basal ganglia and the thalamus; therefore, movement disorders are more frequently manifest after stroke compared with neurological injuries associated with other structures of the brain. Overall clinical features, such as types of movement disorder, the time of onset and prognosis, are similar with movement disorders after stroke in other structures. Dystonia and chorea are commonly occurring post-stroke movement disorders in basal ganglia circuit, and these disorders rarely present with tremor. Rarer movement disorders, including tic, restless leg syndrome, and blepharospasm, can also develop following a stroke. Although the precise mechanisms underlying the pathogenesis of these conditions have not been fully characterized, disruptions in the crosstalk between the inhibitory and excitatory circuits resulting from vascular insult are proposed to be the underlying cause. The GABA (gamma-aminobutyric acid)ergic and dopaminergic systems play key roles in post-stroke movement disorders. This review summarizes movement disorders induced by basal ganglia and thalamic stroke according to the anatomical regions in which they manifest.

Citations

Citations to this article as recorded by  
  • Movement disorders in pediatric stroke survivors: A case series
    Rafaello Ibrado, Annie M. Abraham, Jared Stowers, Melissa Fleming
    PM&R.2025; 17(2): 238.     CrossRef
  • Pairwise hemorrhage-brain region interaction-driven hemorrhagic stroke assessment in CT
    Wei Liang, Haixiong Wu, Hongbin Guo, Zhanyao Huang, Shibin Liang, Jinhuang Zhang, Huiling Zhang, Xiangyuan Ma, Zibi Xu
    Physics in Medicine & Biology.2025; 70(1): 015006.     CrossRef
  • Elucidation of the clinical traits of diabetic chorea through a questionnaire survey of people with diabetic chorea from 59 Japanese hospitals
    Naoko Arakawa, Tomohisa Aoyama, Hirotsugu Suwanai, Gotaro Toda, Iseki Takamoto, Yukiko Okazaki, Takashi Kadowaki, Toshimasa Yamauchi
    Journal of Diabetes Investigation.2025; 16(4): 680.     CrossRef
  • Frequency, phenotypes, and neuroimaging of early post stroke movement disorders: a prospective study
    Eslam Samra, Tamer Roushdy, Amr S. Zaki, Alia H. Mansour, Ahmed Elbassiouny, Ali Shalash
    The Egyptian Journal of Neurology, Psychiatry and Neurosurgery.2025;[Epub]     CrossRef
  • Transcranial direct current stimulation and lesions hierarchically reorganize brain network dynamics with biological annotations
    Jie Chen, Feixue Wang, Lei Zhao, Huijuan Zhang, Zhiyan Wang, Yilan Tang, Xiangyu Chang, Weiwei Ma, Yi Qiu, Yangyang Yi, Fanzhe Fu, Yipeng Yao, Fangyuan Cui, Yihuai Zou, Jin Cao, Yiheng Tu
    Fundamental Research.2025;[Epub]     CrossRef
  • Hemichorea-hemiballismus induced by intravenous thrombolytic therapy for acute ischemic stroke: a case report and literature review
    Weiwei Gao
    American Journal of Translational Research.2025; 17(1): 493.     CrossRef
  • Can blepharospasm and hemifacial spasm spontaneously resolve? A long-term review of facial spasm patients from two large medical centers
    Meydan Ben Ishai, Shiran Manor, Rita Zlatkin, Inbal Avisar, Simerdip Kaur, Saul Rajak
    European Journal of Ophthalmology.2025; 35(6): 2272.     CrossRef
  • Neural mechanisms underlying the improvement of gait disturbances in stroke patients through robot-assisted gait training based on QEEG and fNIRS: a randomized controlled study
    Xiang Li, Huihuang Zhang, Wanying Zhang, Jianing Wu, Lei Dai, Nasha Long, Tiefeng Jin, Lei Gu, Jianer Chen
    Journal of NeuroEngineering and Rehabilitation.2025;[Epub]     CrossRef
  • The effect of mechanical digit sensory stimulation on upper limb motor function recovery in convalescent stroke patients with hemiplegia
    Kexin Yao, Qiqi Li, Yuqin Ma, Yaxing Tian, Shuting Zhang, Yongfeng Hong
    Clinical Neurology and Neurosurgery.2025; 257: 109027.     CrossRef
  • Ausgeprägter behindernder Ballismus nach Schlaganfall – eine interdisziplinäre Herausforderung für die Rehabilitation und ambulante neuropsychiatrische Betreuung
    Hans-Jürgen Gdynia, Peter Schneiderat, Martin Hinterseer, Michael Ertl
    Der Nervenarzt.2025; 96(7): 705.     CrossRef
  • Cancer-related movement disorders: A scoping review and diagnostic approach
    Laura E Schroeder, Ethan Snow, Casandra Chen, Amy Addo, Nahid Mohammadzadeh, Lawrence Recht, Saud Alhusaini
    Neuro-Oncology Practice.2025; 12(6): 970.     CrossRef
  • Holmes Tremor as a Delayed Sequelae of Cerebral Venous Sinus Thrombosis: A Case Report
    Kamalesh Tayade, Amarnath Chavan, Haresh Bharote, Dnyaneshwar Asole, Anil Venkitachalam, Anarya Karle, Jivan Morey
    Annals of Movement Disorders.2025; 8(2): 141.     CrossRef
  • Potential impacts of acupuncture on motor function recovery after ischemic stroke: insights from basic and clinical studies
    Jia-Ling He, Liang-Xiao Ma, Jing-Si Wen, Yu-Xin Zhuang, Xu Qian, Ling-Hui Ma, Jing-Yun Xiu, Xiu-Yan Wang, Meng-Yu Chen
    Frontiers in Cellular Neuroscience.2025;[Epub]     CrossRef
  • A Case Report on Pain and Functional Recovery in a Post-Stroke Shoulder Pain Patient Treated with Korean medicine Centered on Acupotomy
    Hyonjun Chun, Teh-Cheng Sun, Yu-bin Kim, Chang-ho Han, Mikyung Kim
    Journal of Korean Medicine.2025; 46(3): 168.     CrossRef
  • The Rehabilitation Nurse’s Role in the Care of a Stroke Patient With a Movement Disorder
    Sylvia A. Duraski, Kathy May Cacho
    Rehabilitation Nursing Journal.2025; 50(4): 138.     CrossRef
  • Approaches to sensory–motor symptoms in neurological diseases
    Fatih Özden, Mehmet Özkeskin, Miray Baser
    Somatosensory & Motor Research.2025; : 1.     CrossRef
  • A nomogram based on coagulation markers for predicting meige syndrome risk
    Yuanyuan Chen, Yuehua Sun, Xinyu Zhang, Yang Chen, Shuai Zhao, Mengyao Shi, Xuefeng Lv, Wenping Lian, Zhongquan Wang, Yongjun Wu, Yajie Ma, Gang Liu, Mengle Peng
    Frontiers in Aging Neuroscience.2025;[Epub]     CrossRef
  • Secondary parkinsonism associated with focal brain lesions
    Rok Berlot, Anđela Pavlović, Maja Kojović
    Frontiers in Neurology.2024;[Epub]     CrossRef
  • Glucocorticoid receptor antagonist CORT113176 attenuates motor and neuropathological symptoms of Huntington's disease in R6/2 mice
    Max Gentenaar, Fleur L. Meulmeester, Ximaine R. van der Burg, Anna T. Hoekstra, Hazel Hunt, Jan Kroon, Willeke M.C. van Roon-Mom, Onno C. Meijer
    Experimental Neurology.2024; 374: 114675.     CrossRef
  • Hemichorea in patients with temporal lobe infarcts: Two case reports
    Xu-Dong Wang, Xing Li, Chun-Lian Pan
    World Journal of Clinical Cases.2024; 12(4): 806.     CrossRef
  • Movement disorders following mechanical thrombectomy resulting in ischemic lesions of the basal ganglia: An emerging clinical entity
    Leonardo Rigon, Danilo Genovese, Carla Piano, Valerio Brunetti, Valeria Guglielmi, Angelo Tiziano Cimmino, Irene Scala, Salvatore Citro, Anna Rita Bentivoglio, Eleonora Rollo, Riccardo Di Iorio, Aldobrando Broccolini, Roberta Morosetti, Mauro Monforte, Gi
    European Journal of Neurology.2024;[Epub]     CrossRef
  • Human–Robot Cooperation Control Strategy Design Based on Trajectory Deformation Algorithm and Dynamic Movement Primitives for Lower Limb Rehabilitation Robots
    Jie Zhou, Yao Sun, Laibin Luo, Wenxin Zhang, Zhe Wei
    Processes.2024; 12(5): 924.     CrossRef
  • Refined movement analysis in the staircase test reveals differential motor deficits in mouse models of stroke
    Matej Skrobot, Rafael De Sa, Josefine Walter, Arend Vogt, Raik Paulat, Janet Lips, Larissa Mosch, Susanne Mueller, Sina Dominiak, Robert Sachdev, Philipp Boehm-Sturm, Ulrich Dirnagl, Matthias Endres, Christoph Harms, Nikolaus Wenger
    Journal of Cerebral Blood Flow & Metabolism.2024; 44(9): 1551.     CrossRef
  • Dystonic posturing with athetoid movements in stroke without thalamic lesion
    Axel Ferreira, Vanessa Carvalho, Paulo Simões Coelho
    BMJ Case Reports.2023; 16(1): e248977.     CrossRef
  • Monochorea after acute contralateral pontine infarction: A case report
    Yun Su Hwang, Byoung-Soo Shin, Han Uk Ryu, Hyun Goo Kang
    Medicine.2023; 102(3): e32660.     CrossRef
  • Post-stroke Chorea in the Neurology Department of Ignace Deen Hospital of Conakry, Guinea
    Idrissa Doumbouya, Souleymane Djigue Barry, Mohamed Lamine Toure, Djénabou Négué Barry, Karinka Diawara , Mohamed Traoré, Mamadou Hady Diallo, Fodé Abass Cissé, Amara Cissé
    Cureus.2023;[Epub]     CrossRef
  • Striatal fibrinogen extravasation and vascular degeneration correlate with motor dysfunction in an aging mouse model of Alzheimer’s disease
    Hanna E. Berk-Rauch, Arnab Choudhury, Allison T. Richards, Pradeep K. Singh, Zu-Lin Chen, Erin H. Norris, Sidney Strickland, Hyung Jin Ahn
    Frontiers in Aging Neuroscience.2023;[Epub]     CrossRef
  • Constraint-induced movement therapy alleviates motor impairment by inhibiting the accumulation of neutrophil extracellular traps in ischemic cortex
    Congqin Li, Jian Hu, Ying Xing, Jing Han, Anjing Zhang, Yuqian Zhang, Yan Hua, Zhanzhuang Tian, Yulong Bai
    Neurobiology of Disease.2023; 179: 106064.     CrossRef
  • Deep brain stimulation in posterior subthalamic area for Holmes tremor: Case reports with review of the literature
    Hikaru Kamo, Genko Oyama, Masanobu Ito, Hirokazu Iwamuro, Atsushi Umemura, Nobutaka Hattori
    Frontiers in Neurology.2023;[Epub]     CrossRef
  • Síndrome fronto-subcortical: cuando la red falla, a propósito de un caso
    María Noemí García-Calderón Díaz, María Isabel Ramos García
    Revista Española de Geriatría y Gerontología.2023; 58(5): 101379.     CrossRef
  • Functional and structural brain reorganization in patients with ischemic stroke: a multimodality MRI fusion study
    Fangyuan Cui, Lei Zhao, Mengxin Lu, Ruoyi Liu, Qiuyi Lv, Dan Lin, Kuangshi Li, Yong Zhang, Yahui Wang, Yue Wang, Liping Wang, Zhongjian Tan, Yiheng Tu, Yihuai Zou
    Cerebral Cortex.2023; 33(19): 10453.     CrossRef
  • Hypoglycemic Encephalopathy Manifesting with Cortical Hemichorea-Hemiballismus Syndrome: A Case Report
    Francesco Pasini, Aristotelis Karantzoulis, Gaia Fanella, Francesco Brovelli, Davide Iacobucci, Vittoria Aprea, Benedetta Storti, Francesco Santangelo, Francesco Canonico, Paolo Remida, Carlo Ferrarese, Laura Brighina
    Case Reports in Neurology.2023; 15(1): 24.     CrossRef
  • Lesion network mapping of eye-opening apraxia
    Pardis Zarifkar, Nicholas A Shaff, Vardan Nersesjan, Andrew R Mayer, Sephira Ryman, Daniel Kondziella
    Brain Communications.2023;[Epub]     CrossRef
  • Late-onset, first-ever involuntary movement after successful surgical revascularization for pediatric moyamoya disease – Report of two cases
    Shunsuke Hasegawa, Tomomi Tanaka, Shusuke Yamamoto, Daina Kashiwazaki, Kyo Noguchi, Satoshi Kuroda
    Surgical Neurology International.2023; 14: 430.     CrossRef
  • A Rare Pathologic Collecting and Hoarding Behavior Following Left Middle Cerebral Artery Territory Infarction
    Minwoo Lee, Yeo J Kim, Yerim Kim
    Neurology India.2022; 70(3): 1263.     CrossRef
  • Hyperkinetic Choreiform Movements Secondary to Basal Ganglia Calcification and Underlying Developmental Venous Anomaly
    Jay Patel, Muhammad Khalil, Sidra Zafar
    Cureus.2022;[Epub]     CrossRef
  • Case Report: Dystonic Storm Following Japanese Encephalitis Virus Infection
    Ritwik Ghosh, Souvik Dubey, Shambaditya Das, Julián Benito-León
    The American Journal of Tropical Medicine and Hygiene.2022; 107(3): 557.     CrossRef
  • Adult-Onset Idiopathic Cervical Dystonia
    Shameer Rafee, Mahmood Al-Hinai, Michael Hutchinson
    European Medical Journal.2022; : 69.     CrossRef
  • Hemichorea after successful treatment with mechanical thrombectomy in a patient with acute ischemic stroke
    Satoshi Kimura, Jun Tsugawa, Takafumi Mitsutake, Yuji Tateishi, Hayatsura Hanada, Yusuke Morinaga, Ritsuro Inoue, Yoko Hirata, Yusuke Takemura, Kouhei Nii, Yoshio Tsuboi, Toshio Higashi
    Interdisciplinary Neurosurgery.2021; 25: 101156.     CrossRef
  • Post-stroke Movement Disorders
    Priyanka Tater, Sanjay Pandey
    Neurology India.2021; 69(2): 272.     CrossRef
  • Diagnostic Challenges in Outpatient Stroke: Stroke Chameleons and Atypical Stroke Syndromes
    Emma JC Wallace, Ava L Liberman
    Neuropsychiatric Disease and Treatment.2021; Volume 17: 1469.     CrossRef
  • Ischemic stroke-induced polyaxonal innervation at the neuromuscular junction is attenuated by robot-assisted mechanical therapy
    Maria H.H. Balch, Hallie Harris, Deepti Chugh, Surya Gnyawali, Cameron Rink, Shahid M. Nimjee, W. David Arnold
    Experimental Neurology.2021; 343: 113767.     CrossRef
  • Rare coexistence of multiple manifestations secondary to thalamic hemorrhage: A case report
    Qi-Wei Yu, Tian-Fen Ye, Wen-Jun Qian
    World Journal of Clinical Cases.2021; 9(18): 4817.     CrossRef
  • Human–Robot Cooperation Control Based on Trajectory Deformation Algorithm for a Lower Limb Rehabilitation Robot
    Jie Zhou, Zhijun Li, Xianming Li, Xiaoyun Wang, Rong Song
    IEEE/ASME Transactions on Mechatronics.2021; 26(6): 3128.     CrossRef
  • Neurovascular Unit as a Source of Ischemic Stroke Biomarkers—Limitations of Experimental Studies and Perspectives for Clinical Application
    Aleksandra Steliga, Przemysław Kowiański, Ewelina Czuba, Monika Waśkow, Janusz Moryś, Grażyna Lietzau
    Translational Stroke Research.2020; 11(4): 553.     CrossRef
  • Activity‐dependent cleavage of dyskinesia‐related proline‐rich transmembrane protein 2 (PRRT2) by calpain in mouse primary cortical neurons
    Daisuke Hatta, Keiro Shirotani, Yuma Hori, Naohiro Kurotaki, Nobuhisa Iwata
    The FASEB Journal.2020; 34(1): 180.     CrossRef
  • Vascularization of the Subthalamic Nucleus: Highlighting the Significance of the Premamillary Artery
    Serhat Baydin, Oguz Baran, Abuzer Gungor, Enis Kuruoglu, Necmettin Tanriover
    World Neurosurgery.2020; 135: e562.     CrossRef
  • Hemichorea as Presentation of Acute Cortical Ischemic Stroke. Case Series and Review of the Literature
    Álvaro Carbayo, Jordi Sarto, Daniel Santana, Yaroslau Compta, Xabier Urra
    Journal of Stroke and Cerebrovascular Diseases.2020; 29(10): 105150.     CrossRef
  • Differentiating the Brain’s involvement in Executed and Imagined Stepping using fMRI
    Adrienne Kline, Daniel Pittman, Janet Ronsky, Bradley Goodyear
    Behavioural Brain Research.2020; 394: 112829.     CrossRef
  • Hemichorea-hemiballismus as the initial manifestation of symptomatic middle cerebral artery dissection
    Hanfeng Chen, Ziqi Xu
    Medicine.2020; 99(36): e22116.     CrossRef
  • Deficits in motor and cognitive functions in an adult mouse model of hypoxia-ischemia induced stroke
    Li Feng, Chun-Xia Han, Shu-Yu Cao, He-Ming Zhang, Gang-Yi Wu
    Scientific Reports.2020;[Epub]     CrossRef
  • Effectiveness of rehabilitation of patients with cerebrovascular insufficiency using the biofeedback method
    A. V. Rylskiy, A. N. Oranskaya, K. G. Gurevich
    Fizioterapevt (Physiotherapist).2020; (5): 8.     CrossRef
  • A phase IIb, randomised, double-blind, placebo-controlled, dose-ranging investigation of the safety and efficacy of NTCELL® [immunoprotected (alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson's disease
    Barry Snow, Eoin Mulroy, Arnold Bok, Mark Simpson, Andrew Smith, Kenneth Taylor, Michelle Lockhart, BB Janice Lam, Christopher Frampton, Patrick Schweder, Benson Chen, Gregory Finucane, Adele McMahon, Lorraine Macdonald
    Parkinsonism & Related Disorders.2019; 61: 88.     CrossRef
  • 'Stroke chameleons'
    D. A. Demin, V. V. Belopasov, E. V. Asfandiiarova, E. N. Zhuravleva, I. S. Mintulaev, E. V. Nikolaeva
    Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2019; 119(4): 72.     CrossRef
  • Double Hit Theory for the Development of Vascular Parkinsonism
    Herbert Alejandro Manosalva
    Neurophysiology and Rehabilitation.2019; : 42.     CrossRef
  • Deep Brain Stimulation for Intractable Involuntary Movement
    Yoshinori Higuchi, Kyoko Aoyagi, Masaki Izumi, Maidinamu Yakufujiang, Yoji Okahara, Osamu Nagano, Yasuo Iwadate
    Japanese Journal of Neurosurgery.2019; 28(6): 342.     CrossRef
  • Interaction between ventricular expansion and structural changes in the corpus callosum and putamen in males with FMR1 normal and premutation alleles
    Jun Yi Wang, David Hessl, Flora Tassone, Kyoungmi Kim, Randi J. Hagerman, Susan M. Rivera
    Neurobiology of Aging.2019;[Epub]     CrossRef
  • Progressive chorea and dystonia associated with a large arteriovenous malformation
    Jeffrey S Raskin, Mered Parnes, Sandi Lam
    Journal of the International Child Neurology Association.2019;[Epub]     CrossRef
  • Acute-onset Restless legs syndrome in acute neurological conditions-a prospective study on patients with the Guillain-Barre syndrome and acute stroke
    S. Chandan, G. Shukla, A. Gupta, A. Srivastava, D. Vibha, K. Prasad
    Acta Neurologica Scandinavica.2018; 137(5): 488.     CrossRef
  • Levofloxacin-induced hemichorea-hemiballism in a patient with previous thalamic infarction
    Ruggero Bacchin, Francesco Macchione, Davide Cardellini, Riccardo Orlandi, Alberto Gajofatto, Gianluigi Zanusso, Gaetano Vattemi
    Neurological Sciences.2018; 39(8): 1483.     CrossRef
  • Post-Thalamic Stroke Movement Disorders: A Systematic Review
    Navnika Gupta, Sanjay Pandey
    European Neurology.2018; 79(5-6): 303.     CrossRef
  • Individualized Immunological Data for Precise Classification of OCD Patients
    Hugues Lamothe, Jean-Marc Baleyte, Pauline Smith, Antoine Pelissolo, Luc Mallet
    Brain Sciences.2018; 8(8): 149.     CrossRef
  • Dystonia: A Leading Neurological Movement Disorder
    Md. Tanvir Kabir, Hasina Yasmin, Umme Salma Khanam, Mohd. Raeed Jamiruddin, Md. Sahab Uddin, Mohamed M. Abdel-Daim
    Journal of Intellectual Disability - Diagnosis and Treatment.2018; 6(3): 63.     CrossRef
  • Poststroke Choreodystonia Responsive to Zopiclone: Further Evidence of a Role for the “Z‐Drugs” in Hyperkinetic Movement Disorders
    Petya Bogdanova‐Mihaylova, Richard A. Walsh
    Movement Disorders Clinical Practice.2017; 4(4): 616.     CrossRef
  • Vascular Pathology Causing Late Onset Generalized Chorea: A Clinico‐Pathological Case Report
    Paula Salgado, Ricardo Taipa, Joana Domingos, Daniel Dias, Manuel Melo Pires, Marina Magalhães
    Movement Disorders Clinical Practice.2017; 4(6): 819.     CrossRef
Movement Disorders Following Cerebrovascular Lesions in Cerebellar Circuits
Seong-Min Choi
J Mov Disord. 2016;9(2):80-88.   Published online May 25, 2016
DOI: https://doi.org/10.14802/jmd.16004
  • 28,214 View
  • 593 Download
  • 41 Web of Science
  • 34 Crossref
AbstractAbstract PDF
Cerebellar circuitry is important to controlling and modifying motor activity. It conducts the coordination and correction of errors in muscle contractions during active movements. Therefore, cerebrovascular lesions of the cerebellum or its pathways can cause diverse movement disorders, such as action tremor, Holmes’ tremor, palatal tremor, asterixis, and dystonia. The pathophysiology of abnormal movements after stroke remains poorly understood. However, due to the current advances in functional neuroimaging, it has recently been described as changes in functional brain networks. This review describes the clinical features and pathophysiological mechanisms in different types of movement disorders following cerebrovascular lesions in the cerebellar circuits.

Citations

Citations to this article as recorded by  
  • Frequency, phenotypes, and neuroimaging of early post stroke movement disorders: a prospective study
    Eslam Samra, Tamer Roushdy, Amr S. Zaki, Alia H. Mansour, Ahmed Elbassiouny, Ali Shalash
    The Egyptian Journal of Neurology, Psychiatry and Neurosurgery.2025;[Epub]     CrossRef
  • The clinical and neuroradiological features of hypertrophic olivary degeneration following brainstem stroke
    Ziqu Zhang, Wen Jian, Nan Li, Xin Gao, Lin Chen, Xiaowei Zhang, Dan Cai, Jianle He, Yaqiong Nie, Yaoyao Shen
    Neurological Sciences.2025; 46(6): 2697.     CrossRef
  • Hypertrophic olivary degeneration following cerebral infarction: a case report
    Zhuo Qun Li, An Xie
    BMC Neurology.2025;[Epub]     CrossRef
  • Holmes Tremor as a Delayed Sequelae of Cerebral Venous Sinus Thrombosis: A Case Report
    Kamalesh Tayade, Amarnath Chavan, Haresh Bharote, Dnyaneshwar Asole, Anil Venkitachalam, Anarya Karle, Jivan Morey
    Annals of Movement Disorders.2025; 8(2): 141.     CrossRef
  • Clinical characteristics of hypertrophic olivary degeneration following brainstem or cerebellar hemorrhage
    Lin Lin, Xiaofeng Ye, Jianming Zheng
    Scientific Reports.2025;[Epub]     CrossRef
  • Neuroengineering approaches assessing structural and functional changes of motor descending pathways in stroke
    Jordan N Williamson, Rita Huan-Ting Peng, Joohwan Sung, Mahmood Rajabtabar Darvish, Xiaoxi Chen, Mehreen Ali, Sheng Li, Yuan Yang
    Progress in Biomedical Engineering.2025; 7(4): 042006.     CrossRef
  • Hypertrophic olivary degeneration secondary to brain abscess: a case report and literature review
    Shihan Tian, Biqiu Tang, Kai Zhang, Xiaohe Tian, Na Hu
    Frontiers in Human Neuroscience.2025;[Epub]     CrossRef
  • Clinical study of six patients with pure dysarthria and dysarthria—(Central) facial nerve palsy/isolated central facial nerve palsy caused by extracerebellar infarction
    Katsuhiko Ogawa, Takayoshi Akimoto, Makoto Hara, Midori Fujishiro, Hideto Nakajima
    Neurology and Clinical Neuroscience.2024; 12(2): 100.     CrossRef
  • Flapping Tremor: Unraveling Asterixis—A Narrative Review
    Jamir Pitton Rissardo, Sara Muhammad, Venkatesh Yatakarla, Nilofar Murtaza Vora, Paras Paras, Ana Letícia Fornari Caprara
    Medicina.2024; 60(3): 362.     CrossRef
  • Influencing factors of corticomuscular coherence in stroke patients
    Zhixian Gao, Shiyang Lv, Xiangying Ran, Yuxi Wang, Mengsheng Xia, Junming Wang, Mengyue Qiu, Yinping Wei, Zhenpeng Shao, Zongya Zhao, Yehong Zhang, Xuezhi Zhou, Yi Yu
    Frontiers in Human Neuroscience.2024;[Epub]     CrossRef
  • Hypertrophic olivary degeneration following head injury: a case report
    Neha Singh, Kishan Kumar Thakur, Deepak Kumar Singh, James Marak
    Egyptian Journal of Radiology and Nuclear Medicine.2024;[Epub]     CrossRef
  • Meningioma‑associated parkinsonism related to basal ganglia and cerebellar motor circuits: A case report and literature review
    Shintaro Takeda, Shohei Nagasaka, Kohei Suzuki, Koichiro Futatsuya, Junkoh Yamamoto
    Experimental and Therapeutic Medicine.2024;[Epub]     CrossRef
  • Unveiling Benedikt’s syndrome: A rare midbrain stroke presenting with oculomotor nerve palsy
    Arumugam Balraj, Sunil Kumar
    Indian Journal of Ophthalmology - Case Reports.2024; 4(4): 908.     CrossRef
  • Genome-wide association study of cerebellar white matter microstructure and genetic overlap with common brain disorders
    Bang-Sheng Wu, Yi-Jun Ge, Wei Zhang, Shi-Dong Chen, Shi-Tong Xiang, Ya-Ru Zhang, Ya-Nan Ou, Yu-Chao Jiang, Lan Tan, Wei Cheng, John Suckling, Jian-Feng Feng, Jin-Tai Yu, Ying Mao
    NeuroImage.2023; 269: 119928.     CrossRef
  • Deep Brain Stimulation for Holmes Tremors and Literature Review
    Kunkala Lavanya, P. Vijaya Shankar, K. Visvanathan, S. Sundar, P. Philohazeena
    Annals of Indian Academy of Neurology.2023; 26(3): 296.     CrossRef
  • The Guillain-Mollaret triangle: a key player in motor coordination and control with implications for neurological disorders
    Eren Ogut, Kutay Armagan, Doruktan Tufekci
    Neurosurgical Review.2023;[Epub]     CrossRef
  • Morphological and Functional Principles Governing the Plasticity Reserve in the Cerebellum: The Cortico-Deep Cerebellar Nuclei Loop Model
    Hiroshi Mitoma, Shinji Kakei, Hirokazu Tanaka, Mario Manto
    Biology.2023; 12(11): 1435.     CrossRef
  • Holmes tremor: an updated review
    Efstratios-Stylianos Pyrgelis, Eleni Agapiou, Efthalia Angelopoulou
    Neurological Sciences.2022; 43(12): 6731.     CrossRef
  • Post-stroke Movement Disorders
    Priyanka Tater, Sanjay Pandey
    Neurology India.2021; 69(2): 272.     CrossRef
  • Delayed cervicobrachial segmental dystonia secondary to ipsilateral cerebellar infarction
    Vikram V. Holla, Sudhakar Pushpa Chaithra, Shweta Prasad, Pramod Kumar Pal
    Annals of Movement Disorders.2021; 4(2): 89.     CrossRef
  • Pathophysiology of Cerebellar Tremor: The Forward Model-Related Tremor and the Inferior Olive Oscillation-Related Tremor
    Shinji Kakei, Mario Manto, Hirokazu Tanaka, Hiroshi Mitoma
    Frontiers in Neurology.2021;[Epub]     CrossRef
  • Case Report: Dual Target Deep Brain Stimulation With Externalized Programming for Post-traumatic Complex Movement Disorder
    Ron Gadot, Ben Shofty, Ricardo A. Najera, Adrish Anand, Garrett Banks, Abdul Basit Khan, Melissa A. LoPresti, Nora Vanegas Arroyave, Sameer A. Sheth
    Frontiers in Neuroscience.2021;[Epub]     CrossRef
  • Gadolinium-based contrast agents – what is the evidence for ‘gadolinium deposition disease’ and the use of chelation therapy?
    Kerry A. Layne, David M. Wood, Paul I. Dargan
    Clinical Toxicology.2020; 58(3): 151.     CrossRef
  • POLR3A variants with striatal involvement and extrapyramidal movement disorder
    Inga Harting, Murtadha Al-Saady, Ingeborg Krägeloh-Mann, Annette Bley, Maja Hempel, Tatjana Bierhals, Stephanie Karch, Ute Moog, Geneviève Bernard, Richard Huntsman, Rosalina M. L. van Spaendonk, Maaike Vreeburg, Agustí Rodríguez-Palmero, Aurora Pujol, Ma
    neurogenetics.2020; 21(2): 121.     CrossRef
  • Ataxic hemiparesis after corona radiata infarct: Diffusion tensor imaging correlation of corticoponto-cerebellar tract injury
    Jun Young Kim, Jeong Pyo Seo, Min Cheol Chang
    Translational Neuroscience.2020; 11(1): 1.     CrossRef
  • The Rehapiano—Detecting, Measuring, and Analyzing Action Tremor Using Strain Gauges
    Norbert Ferenčík, Miroslav Jaščur, Marek Bundzel, Filippo Cavallo
    Sensors.2020; 20(3): 663.     CrossRef
  • Oxygen Cost During Walking in Individuals With Stroke: Hemiparesis Versus Cerebellar Ataxia
    Maxence Compagnat, Jean-Christophe Daviet, Charles Batcho, Nicolas Vuillerme, Jean-Yves Salle, Romain David, Stephane Mandigout
    Neurorehabilitation and Neural Repair.2020; 34(4): 289.     CrossRef
  • An Observational Study of Social Interaction Skills and Behaviors in Cornelia de Lange, Fragile X and Rubinstein-Taybi Syndromes
    Katherine Ellis, Chris Oliver, Chrysi Stefanidou, Ian Apperly, Jo Moss
    Journal of Autism and Developmental Disorders.2020; 50(11): 4001.     CrossRef
  • Injury of the dentato-rubro-thalamic tract in a patient with intentional tremor after mild traumatic brain injury: a case report
    Min Cheol Chang, Jeong Pyo Seo
    Brain Injury.2020; 34(9): 1283.     CrossRef
  • KCND3-Related Neurological Disorders: From Old to Emerging Clinical Phenotypes
    Luca Pollini, Serena Galosi, Manuela Tolve, Caterina Caputi, Carla Carducci, Antonio Angeloni, Vincenzo Leuzzi
    International Journal of Molecular Sciences.2020; 21(16): 5802.     CrossRef
  • Posterior Subthalamic Area Deep Brain Stimulation for Treatment of Refractory Holmes Tremor
    Malgorzata Dec-Ćwiek, Marcin Tutaj, Wojciech Pietraszko, Witold Libionka, Mariusz Krupa, Marek Moskała, Monika Rudzińska-Bar, Agnieszka Słowik, Joanna Pera
    Stereotactic and Functional Neurosurgery.2019; 97(3): 183.     CrossRef
  • Teaching Video NeuroImages: A patient with Holmes tremor due to demyelinating lesion of the inferior cerebellar peduncle
    Daniel G. Di Luca, Andres De Leon-Benedetti, Stacey Williamson, Le Treice Irving, Jason Margolesky
    Neurology.2019;[Epub]     CrossRef
  • Acute hemorrhagic cerebellar infarction presenting with isolated head titubation
    Tatsuya Ueno, Haruo Nishijima, Akira Arai, Masahiko Tomiyama
    Journal of the Neurological Sciences.2017; 372: 456.     CrossRef
  • Rubral Tremor Associated with Klinefelter Syndrome: A Case Report and Literature Review
    Reihaneh Dehghani, Elmira Agah, Zeinab Falsafi, Abbas Tafakhori
    Archives of Neuroscience.2017;[Epub]     CrossRef
Original Article
Movement Disorders in Non-Wilsonian Cirrhotic Patients: A Report of the Prevalence and Risk Factors from a Study Done in a Medical School in an Agricultural-Based Community
Kulthida Methawasin, Piyanant Chonmaitree, Chatchawan Wongjitrat, Suthee Rattanamongkolgul, Thanin Asawavichienjinda
J Mov Disord. 2016;9(1):28-34.   Published online December 3, 2015
DOI: https://doi.org/10.14802/jmd.15034
  • 21,935 View
  • 86 Download
  • 2 Crossref
AbstractAbstract PDF
Objective
Parkinsonism and other movement disorders have previously been reported in the acquired hepatocerebral degeneration associated with portosystemic shunting. However, there is no study to date about their prevalence as has been noted in general practice.
Methods
One hundred and forty-three patients with hepatic cirrhosis from the gastroenterology clinic and internal medicine wards were enrolled. Liver data included the diagnoses, etiologies, assessments of complications, and treatments for cirrhosis. Hepatic encephalopathy was classified with regard to the West Haven criteria for semi-quantitative grading for mental status. Neurological examination results and abnormal involuntary movements were recorded as primary outcomes. Neuro-radiology was used for the detection of severe brain lesions.
Results
Alcoholism was the most common cause of liver cirrhosis. Eighty-three patients (58%) presented with movement disorders. Asterixis was found in one of the cases. The most common movement disorder seen was an intentional tremor at 37.1%, which was followed by bradykinesia, Parkinsonism, and postural tremors at 29.4%, 10.5%, and 6.3%, respectively. The prevalence of movement disorders simultaneously increased with a high Child-Turcotte-Pugh score. The hepatic encephalopathy was grade 1 and 2. With the inclusion of age-range adjustments, we found that alcoholic cirrhosis and hepatic encephalopathy are statistically significant factors [p < 0.05, odds ratio (OR) = 6.41, 95% confidence interval (CI) 1.38–29.71 and p < 0.001, OR = 13.65, 95% CI 4.71–39.54] for the development of movement disorders in non-Wilsonian cirrhotic patients. Conclusions Intentional tremor is a common abnormal movement. Alcoholic cirrhosis and hepatic encephalopathy are significant risk factors in the development of movement disorders in non-Wilsonian cirrhotic patients.

Citations

Citations to this article as recorded by  
  • Investigating the Relationship between Chronic Liver Cirrhosis and Parkinsonism: A Comparative Analysis and a Suggested Diagnostic Scheme
    Tal Sigawi, Omer Hamtzany, Noa Hurvitz, Yuval Ishay, Roy Dayan, David Arkadir, Yaron Ilan
    Clinics and Practice.2024; 14(4): 1375.     CrossRef
  • A Prospective Study of the Prevalence of Parkinsonism in Patients With Liver Cirrhosis
    Diana Apetauerova, Peter Hildebrand, Stephanie Scala, Janet W. Zani, LeeAnne Lipert, Erin Clark, Tanya Fennell, Fredric D. Gordon
    Hepatology Communications.2021; 5(2): 323.     CrossRef
Review Article
The Current Status of Deep Brain Stimulation for the Treatment of Parkinson Disease in the Republic of Korea
Jung-Il Lee
J Mov Disord. 2015;8(3):115-121.   Published online September 10, 2015
DOI: https://doi.org/10.14802/jmd.15043
  • 25,037 View
  • 128 Download
  • 14 Web of Science
  • 14 Crossref
AbstractAbstract PDF
Parkinson disease (PD) is a common neurodegenerative disease with an increasing prevalence in Korea. Deep brain stimulation (DBS) is a safe and effective surgical treatment option for this disease. The aim of this review was to provide an update regarding current DBS practices with respect to the treatment of PD in the Republic of Korea. The first DBS in Korea was performed in 2000; approximately 2,000 patients have undergone DBS for a variety of neurological disorders, the majority of whom were patients with PD. Approximately 150 new patients with PD receive DBS annually, and more than 20 centers perform DBS. However, DBS remains underutilized for many reasons, and the clinical case burden at many institutions is below the level presumed adequate for qualified practice. With a rapidly aging population and an evolving socioeconomic environment, the need for surgical intervention for PD is likely to increase significantly in the future. Many issues such as finances, education, and quality assurance must be resolved to cope with this need.

Citations

Citations to this article as recorded by  
  • Self-Care Experiences and Behaviours in People With Parkinson’s Disease: A Meta-Synthesis
    Monica Petralito, Chiara Tedesco, Ercole Vellone, Silvia Cilluffo, Maura Lusignani, Stefano Terzoni, Andrea Zanichelli, Rosario Caruso, Gianluca Pucciarelli
    Journal of Geriatric Psychiatry and Neurology.2025;[Epub]     CrossRef
  • Disparities in Access to Deep Brain Stimulation
    Franziska A. Schmidt, Irene Martinez-Torres, Jürgen Germann, Mohammad Mehdi Hajiabadi, Oliver Bichsel, Can Sarica, Andres M. Lozano
    Stereotactic and Functional Neurosurgery.2025; : 1.     CrossRef
  • Problems in organizing neurosurgical care for patients with Parkinson’s disease in the Russian Federation
    A.A. Tomskiy, E.V. Bril, A.A. Gamaleya, A.A. Poddubskaya, N.V. Fedorova, O.S. Levin, S.N. Illarioshkin
    Burdenko's Journal of Neurosurgery.2024; 88(3): 5.     CrossRef
  • Deep Learning and fMRI-Based Pipeline for Optimization of Deep Brain Stimulation During Parkinson’s Disease Treatment: Toward Rapid Semi-Automated Stimulation Optimization
    Jianwei Qiu, Afis Ajala, John Karigiannis, Jürgen Germann, Brendan Santyr, Aaron Loh, Luca Marinelli, Thomas Foo, Radhika Madhavan, Desmond Yeo, Alexandre Boutet, Andres Lozano
    IEEE Journal of Translational Engineering in Health and Medicine.2024; 12: 589.     CrossRef
  • The treatment gap for deep brain stimulation in Parkinson’s disease: a comparative analysis of cost and utilisation in high-income countries
    Athena Stein, Nathan Higgins, Mehul Gajwani, Christian A. Gericke
    Australian Health Review.2024; 48(5): 497.     CrossRef
  • Minimising the rate of vascular complications in Deep Brain Stimulation surgery for the management of Parkinson’s disease: a single-centre 600-patient case series
    Raymond Cook, Nyssa Chennell Dutton, Peter A Silburn, Linton J Meagher, George Fracchia, Nathan Anderson, Glen Cooper, Hoang-Mai Dinh, Stuart J Cook, Paul Silberstein
    BMJ Neurology Open.2024; 6(2): e000793.     CrossRef
  • Immunomodulatory and endocrine effects of deep brain stimulation and spinal cord stimulation – A systematic review
    Oskar Puk, Magdalena Jabłońska, Paweł Sokal
    Biomedicine & Pharmacotherapy.2023; 168: 115732.     CrossRef
  • Practice Trends of Neuromodulation Therapies for Pain and Spasticity in India
    Preeti P. Doshi, Marc Russo, Paresh K. Doshi
    Neuromodulation: Technology at the Neural Interface.2021;[Epub]     CrossRef
  • An International Survey of Deep Brain Stimulation Utilization in Asia and Oceania: The DBS Think Tank East
    Chencheng Zhang, Adolfo Ramirez-Zamora, Fangang Meng, Zhengyu Lin, Yijie Lai, Dianyou Li, Jinwoo Chang, Takashi Morishita, Tooru Inoue, Shinsuke Fujioka, Genko Oyama, Terry Coyne, Valerie Voon, Paresh K. Doshi, Yiwen Wu, Jun Liu, Bhavana Patel, Leonardo A
    Frontiers in Human Neuroscience.2020;[Epub]     CrossRef
  • Functional neurosurgery in Parkinson’s disease in Russia
    А.A. Tomskiy, E.V. Bril, A.A. Gamaleya, N.V. Fedorova, O.S. Levin
    Annals of Clinical and Experimental Neurology.2019;[Epub]     CrossRef
  • Canadian Assessment of Deep Brain Stimulation Access: The Canada Study
    C. Michael Honey, Armaan K. Malhotra, Mandeep S. Tamber, Michel Prud’homme, Ivar Mendez, Christopher R. Honey
    Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.2018; 45(5): 553.     CrossRef
  • Association of Parkinsonism or Parkinson Disease with Polypharmacy in the Year Preceding Diagnosis: A Nested Case–Control Study in South Korea
    Hae-Young Park, Ji-Won Park, Hyun Soon Sohn, Jin-Won Kwon
    Drug Safety.2017; 40(11): 1109.     CrossRef
  • La Enfermedad de Parkinson: Etiología, Tratamientos y Factores Preventivos
    F Hurtado, Melissa Andrea N Cardenas, Fernando Cardenas, Laura Andrea León
    Universitas Psychologica.2017;[Epub]     CrossRef
  • Isolated dystypia after subthalamic nucleus deep brain stimulation in a patient with Parkinson’s disease
    Si-Hoon Lee, Kipyung Jeon, Byung-chul Son, Joong-Seok Kim
    Acta Neurochirurgica.2016; 158(4): 783.     CrossRef
Case Report
Giant Middle Fossa Epidermoid Presenting as Holmes’ Tremor Syndrome
Bindu Menon, P Sasikala, Amit Agrawal
J Mov Disord. 2014;7(1):22-24.   Published online April 30, 2014
DOI: https://doi.org/10.14802/jmd.14005
  • 12,074 View
  • 68 Download
  • 4 Web of Science
  • 2 Crossref
AbstractAbstract PDF
Intracranial dermoids may gradually reach an enormous size before the onset of symptoms. Common clinical presentations of intracranial epidermoid include headache and seizures. We present a case of a 35-year female patient with giant middle fossa epidermoid that presented with Holmes’ tremor syndrome, and we review the relevant literature. To the best of our knowledge, such a presentation has not previously been described in the literature.

Citations

Citations to this article as recorded by  
  • Holmes tremor
    Gabriela B. Raina, Maria G. Cersosimo, Silvia S. Folgar, Juan C. Giugni, Cristian Calandra, Juan P. Paviolo, Veronica A. Tkachuk, Carlos Zuñiga Ramirez, Andrea L. Tschopp, Daniela S. Calvo, Luis A. Pellene, Marcela C. Uribe Roca, Miriam Velez, Rolando J.
    Neurology.2016; 86(10): 931.     CrossRef
  • Movement Disorders Following Cerebrovascular Lesions: Etiology, Treatment Options and Prognosis
    Do-Young Kwon
    Journal of Movement Disorders.2016; 9(2): 63.     CrossRef
Review Articles
Electrophysiologic Evaluation of Psychogenic Movement Disorders
Pramod Kumar Pal
J Mov Disord. 2011;4(1):21-32.
DOI: https://doi.org/10.14802/jmd.11004
  • 36,832 View
  • 413 Download
  • 9 Crossref
AbstractAbstract PDF

Psychogenic movement disorders (PMD) are a group of disorders which are in the border zone between neurology and psychiatry. All necessary laboratory investigations should be done to rule out an underlying organic disorder. While clinical acumen of a trained movement disorder specialist may be sufficient to diagnose most PMD, there are clinical situations where electrophysiological tests are required either to rule out an organic movement disorder or even diagnose a PMD. Current electrophysiological test are most useful for tremor, followed by jerks and least for spasms or dystonia. Commonly used electrophysiologic tests include multichannel surface electromyography (EMG), accelerometry, electroencephalography time locked with EMG, premovement potential (Bereitschaftspotential), and somatosensory evoked potentials. Psychogenic tremor is a low frequency tremor with variable frequency and duration of EMG bursts, entrainable, has a high coherence with voluntary movements, and presence of coactivation sign. Patients with psychogenic jerks have well organized triphasic pattern of activation of agonist and antagonist muscles. The jerks are associated with EMG bursts of long duration (usually > 70 ms), long and variable latencies in stimulus induced jerks, absence of craniocaudal pattern of muscle recruitment in apparent startle response, and often a Breitschaftspotential (premovement potential) precedes the jerk. Electrophysiological characterization of psychogenic dystonia is difficult and the tests are usually performed to rule out organic dystonia with characteristic findings. Finally, caution should be exerted in interpreting the electrophysiological tests as both false positive and false negative diagnosis of PMD may still occur.

Citations

Citations to this article as recorded by  
  • Functional Tremor
    Kartika Gulati, Sanjay Pandey
    Seminars in Neurology.2025;[Epub]     CrossRef
  • Investigation of Phase Shifts Using AUC Diagrams: Application to Differential Diagnosis of Parkinson’s Disease and Essential Tremor
    Olga S. Sushkova, Alexei A. Morozov, Ivan A. Kershner, Margarita N. Khokhlova, Alexandra V. Gabova, Alexei V. Karabanov, Larisa A. Chigaleichick, Sergei N. Illarioshkin
    Sensors.2023; 23(3): 1531.     CrossRef
  • Electrophysiology in Functional Movement Disorders: An Update
    Nitish Kamble, Pramod Kumar Pal
    Tremor and Other Hyperkinetic Movements.2023;[Epub]     CrossRef
  • Video electroencephalogram combined with electromyography in the diagnosis of hyperkinetic movement disorders with an unknown cause
    Jianhua Chen, Xiangqin Zhou, Qiang Lu, Liri Jin, Yan Huang
    Neurological Sciences.2021; 42(9): 3801.     CrossRef
  • Suggestibility as a valuable criterion for laboratory-supported definite functional movement disorders
    Gerard Saranza, Daniel Vargas-Mendez, Anthony E. Lang, Robert Chen
    Clinical Neurophysiology Practice.2021; 6: 103.     CrossRef
  • Principles of Electrophysiological Assessments for Movement Disorders
    Kai-Hsiang Stanley Chen, Robert Chen
    Journal of Movement Disorders.2020; 13(1): 27.     CrossRef
  • A case of abdominal functional myoclonus analyzed by movement related cortical potentials
    Ryosuke Urabe, Masaya Kubota
    Brain and Development.2020; 42(9): 700.     CrossRef
  • Focal localized enhanced physiological tremor after physical insult
    Sang-Won Yoo, Myungah Lee, Joong-Seok Kim, Kwang-Soo Lee
    Neurological Sciences.2019; 40(12): 2641.     CrossRef
  • Sleep-Related Movement Disorders: Hypnic Jerks
    Robyn Whitney, Shelly K. Weiss
    Current Sleep Medicine Reports.2018; 4(1): 19.     CrossRef
Electrophysiological Evidences of Organization of Cortical Motor Information in the Basal Ganglia
Hirokazu Iwamuro
J Mov Disord. 2011;4(1):8-12.
DOI: https://doi.org/10.14802/jmd.11002
  • 15,559 View
  • 93 Download
  • 2 Crossref
AbstractAbstract PDF

During the last two decades, the many developments in the treatment of movement disorders such as Parkinson disease and dystonia have enhanced our understanding on organization of the basal ganglia, and this knowledge has led to other advances in the field. According to many electrophysiological and anatomical findings, it is considered that motor information from different cortical areas is processed through several cortico-basal ganglia loops principally in a parallel fashion and somatotopy from each cortical area is also well preserved in each loop. Moreover, recent studies suggest that not only the parallel processing but also some convergence of information occur through the basal ganglia. Information from cortical areas whose functions are close to each other tends to converge in the basal ganglia. The cortico-basal ganglia loops should be comprehended more as a network rather than as separated subdivisions. However, the functions of this convergence still remain unknown. It is important even for clinical doctors to be well informed about this kind of current knowledge because some symptoms of movement disorders may be explained by disorganization of the information network in the basal ganglia.

Citations

Citations to this article as recorded by  
  • Striatal stimulation causing movements mimicking faciobrachial dystonic seizures
    Kia Gilani, Madeline Fields, Dina Bolden, Matthew Davitz, Richard Wennberg
    Epileptic Disorders.2025;[Epub]     CrossRef
  • Parvalbumin+and Npas1+Pallidal Neurons Have Distinct Circuit Topology and Function
    Arin Pamukcu, Qiaoling Cui, Harry S. Xenias, Brianna L. Berceau, Elizabeth C. Augustine, Isabel Fan, Saivasudha Chalasani, Adam W. Hantman, Talia N. Lerner, Simina M. Boca, C. Savio Chan
    The Journal of Neuroscience.2020; 40(41): 7855.     CrossRef

JMD : Journal of Movement Disorders Twitter
Close layer
TOP